WO2022145163A1 - Composition for oral cavity - Google Patents
Composition for oral cavity Download PDFInfo
- Publication number
- WO2022145163A1 WO2022145163A1 PCT/JP2021/043896 JP2021043896W WO2022145163A1 WO 2022145163 A1 WO2022145163 A1 WO 2022145163A1 JP 2021043896 W JP2021043896 W JP 2021043896W WO 2022145163 A1 WO2022145163 A1 WO 2022145163A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oral composition
- sodium
- mass
- sulfate
- component
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 210000000214 mouth Anatomy 0.000 title abstract description 12
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 8
- WXABJFUNSDXVNH-UHFFFAOYSA-N 5-methyl-2-propan-2-yl-n-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NCCC1=CC=CC=N1 WXABJFUNSDXVNH-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims abstract description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims abstract description 3
- -1 2-hydroxy-2-phenylethyl Chemical group 0.000 claims description 65
- 235000002639 sodium chloride Nutrition 0.000 claims description 33
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 28
- 239000000194 fatty acid Substances 0.000 claims description 28
- 229930195729 fatty acid Natural products 0.000 claims description 28
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 23
- 239000000551 dentifrice Substances 0.000 claims description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 7
- 239000004359 castor oil Substances 0.000 claims description 7
- 235000019438 castor oil Nutrition 0.000 claims description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 7
- 235000011152 sodium sulphate Nutrition 0.000 claims description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 239000002736 nonionic surfactant Substances 0.000 claims description 6
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 150000005215 alkyl ethers Chemical class 0.000 claims description 5
- 235000010216 calcium carbonate Nutrition 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 4
- 239000001095 magnesium carbonate Substances 0.000 claims description 4
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 4
- LCQXXBOSCBRNNT-UHFFFAOYSA-K ammonium aluminium sulfate Chemical compound [NH4+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCQXXBOSCBRNNT-UHFFFAOYSA-K 0.000 claims description 3
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 claims description 3
- 229910000020 calcium bicarbonate Inorganic materials 0.000 claims description 3
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 claims description 3
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 claims description 3
- 239000002370 magnesium bicarbonate Substances 0.000 claims description 3
- 235000014824 magnesium bicarbonate Nutrition 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 235000011147 magnesium chloride Nutrition 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 239000002324 mouth wash Substances 0.000 claims description 3
- 229940051866 mouthwash Drugs 0.000 claims description 3
- BPLYVSYSBPLDOA-GYOJGHLZSA-N n-[(2r,3r)-1,3-dihydroxyoctadecan-2-yl]tetracosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)CCCCCCCCCCCCCCC BPLYVSYSBPLDOA-GYOJGHLZSA-N 0.000 claims description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 3
- 239000011736 potassium bicarbonate Substances 0.000 claims description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 3
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 3
- 235000011151 potassium sulphates Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 210000004268 dentin Anatomy 0.000 claims description 2
- PIXYARPXLBNXJR-UHFFFAOYSA-N 4,4-dimethylcyclohexane-1-carboxamide Chemical compound CC1(C)CCC(C(N)=O)CC1 PIXYARPXLBNXJR-UHFFFAOYSA-N 0.000 claims 1
- 150000003841 chloride salts Chemical class 0.000 claims 1
- ILXQRAXCLBJOAD-UHFFFAOYSA-N N-(2-hydroxy-2-phenylethyl)-5,5-dimethyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)(C)CC1C(=O)NCC(O)c1ccccc1 ILXQRAXCLBJOAD-UHFFFAOYSA-N 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 150000001805 chlorine compounds Chemical class 0.000 abstract description 2
- 229940034610 toothpaste Drugs 0.000 abstract description 2
- 239000000606 toothpaste Substances 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 26
- 150000003839 salts Chemical class 0.000 description 20
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 11
- 239000011230 binding agent Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229960003237 betaine Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 150000005846 sugar alcohols Chemical class 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 235000019606 astringent taste Nutrition 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 239000000080 wetting agent Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000003082 abrasive agent Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000004711 α-olefin Substances 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 150000008051 alkyl sulfates Chemical class 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241000723438 Cercidiphyllum japonicum Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- 229940037003 alum Drugs 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical class C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 239000009637 wintergreen oil Substances 0.000 description 2
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical class C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- GRWFGVWFFZKLTI-YGPZHTELSA-N (5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene Chemical compound C1C2CC=C(C)[C@]1([H])C2(C)C GRWFGVWFFZKLTI-YGPZHTELSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HVNMCCPQUIEPCT-UHFFFAOYSA-N 2-(dimethylazaniumyl)pentanoate Chemical compound CCCC(N(C)C)C(O)=O HVNMCCPQUIEPCT-UHFFFAOYSA-N 0.000 description 1
- LBIZZGIYNNLXQN-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid Chemical class CCCCCCCCCCCCOC(=O)CS(O)(=O)=O LBIZZGIYNNLXQN-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ILKFYYOGOCVZRU-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid Chemical class CCCCCCCCCCCC(=O)NCCC(O)=O ILKFYYOGOCVZRU-UHFFFAOYSA-N 0.000 description 1
- HKJKXDULJBGDED-UHFFFAOYSA-N 3-(tetradecylamino)propanoic acid Chemical class CCCCCCCCCCCCCCNCCC(O)=O HKJKXDULJBGDED-UHFFFAOYSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical class CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical class CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical class CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-USWWRNFRSA-N Neomenthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1OC(C)=O XHXUANMFYXWVNG-USWWRNFRSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000862969 Stella Species 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 229920006311 Urethane elastomer Polymers 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Chemical class C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical class CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 229940070800 myristoyl glutamate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- URLJMZWTXZTZRR-UHFFFAOYSA-N sodium myristyl sulfate Chemical compound CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940095068 tetradecene Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to an oral composition.
- Oral compositions such as dentifrices are usually blended with abrasives, surfactants, wetting agents, binders and the like, and nonionic surfactants and the like foam as surfactants to ensure cleanability and the like. Is used for. Further, a method of removing stickiness in the oral cavity and giving a refreshing feeling by adding sodium hydrogen carbonate or other salts has been publicized as well as a physical cleaning feeling with an abrasive or the like. However, sodium hydrogen carbonate and other salts have a refreshing feeling as well as a convergent taste, a peculiar sarcasm, and irritation, which have been problems.
- Patent Document 1 states that by blending a specific amide betaine-type amphoteric tenside into an oral composition using sodium hydrogen carbonate and sodium lauryl sulfate in combination, mucosal irritation could be alleviated while maintaining a refreshing feeling.
- Patent Document 2 describes that the development of astringency by sodium hydrogen carbonate is suppressed by adding glycine, alanine, leucine, glutamic acid and salts thereof to an oral composition containing a hydrogen carbonate or the like.
- Patent Document 3 contains one or more waxes selected from lanolin and its derivatives, whale wax, carnauba wax, candelilla wax, and beeswax in an oral composition containing a converging compound such as baking soda. It is described that this can improve the astringency of sodium hydrogen carbonate.
- Patent Document 1 is insufficient for improving the convergent taste (convergent feeling). Further, the techniques of Patent Documents 2 and 3 are also insufficient for suppressing the astringent taste, and there is room for improvement in terms of the sustainability of the astringent taste suppressing effect. Convergence (convergence) may lead to discomfort, especially for young people, and the development of means for suppressing it is expected.
- An object of the present invention is to provide an oral composition capable of eliminating stickiness in the oral cavity, obtaining a refreshing feeling (exhilarating feeling), suppressing a feeling of convergence, and sustaining the effect of suppressing the feeling of convergence. To do.
- the present invention provides the following [1] to [8].
- [1] One or more selected from the group consisting of (A) carbonate, hydrogen carbonate, sulfate, and chloride, and (B) N- (2-hydroxy-2-phenylethyl) -2-isopropyl-.
- the carbonate is at least one selected from the group consisting of sodium carbonate, potassium carbonate, and magnesium carbonate;
- Bicarbonate is at least one selected from the group consisting of sodium hydrogen carbonate, potassium hydrogen carbonate, calcium hydrogen carbonate, and magnesium hydrogen carbonate;
- the sulfate is at least one selected from the group consisting of sodium sulfate, potassium sulfate, magnesium sulfate, potassium aluminum sulfate, sodium aluminum sulfate, and ammonium aluminum sulfate;
- the chloride is sodium chloride, potassium chloride, and At least one selected from the group consisting of magnesium chloride.
- [7] The oral composition according to [5] or [6], wherein the content of the component (C) is 0.1 to 1% by mass.
- [8] The oral composition according to any one of [1] to [7], which is a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
- an oral composition capable of eliminating stickiness in the oral cavity, obtaining a refreshing feeling, suppressing a feeling of convergence, and sustaining the effect of suppressing the feeling of convergence. ..
- the oral composition of the present invention contains the following components (A) and (B), and preferably further contains the component (C).
- the component (A) is at least one selected from the group consisting of carbonates, bicarbonates, sulfates, and chlorides. By containing the component (A), a refreshing feeling can be imparted to the oral composition.
- the component (B) is ethyl-3- (p-menthan-3-carboxamide) acetate
- the component (A) consists of other than sodium sulfate, that is, carbonate, bicarbonate, aluminum sulfate and chloride.
- One or more species selected from the group is selected from the group.
- Examples of the carbonate include sodium carbonate, potassium carbonate, and magnesium carbonate.
- Examples of the hydrogen carbonate include sodium hydrogen carbonate, potassium hydrogen carbonate, calcium hydrogen carbonate, and magnesium hydrogen carbonate.
- Examples of the sulfate include sodium sulfate, potassium sulfate, magnesium sulfate, aluminum sulfate, and alum.
- Examples of alum include potassium aluminum sulfate, sodium aluminum sulfate, and ammonium aluminum sulfate.
- Examples of the chloride include sodium chloride, potassium chloride and magnesium chloride. Among these, sodium hydrogen carbonate, sodium chloride, and potassium aluminum sulfate are preferable.
- the component (A) may be one kind or a combination of two or more kinds.
- the content of the component (A) is usually 0.05% by mass or more, preferably 0.1% by mass or more, more preferably 0.2% by mass or more, based on the entire oral composition (100% by mass). Is. This can give a refreshing feeling.
- the upper limit is usually 20% by mass or less, preferably 10% by mass or less, and more preferably 5% by mass or less. This makes it possible to suppress the development of a feeling of convergence. Therefore, the content of the component (A) is usually 0.05 to 20% by mass, preferably 0.1 to 10% by mass, more preferably 0.2 to 10% by mass, and further preferably 0.2 to 0.2 to 10% by mass. It is 5% by mass.
- the components (B) are N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide, ethyl-3- (p-menthane-3-carboxamide) acetate and N.
- -(2- (2-Pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexane Carboxamide is one or more selected from the group.
- the component (B) may be one kind or a combination of two or more kinds, but N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide and N- (2).
- -(2-Pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide is preferably contained.
- the effect of suppressing the feeling of convergence can be further sustained, and a better feeling of refreshment can be imparted.
- the content of the component (B) is usually 0.000001% by mass or more, preferably 0.00001% by mass or more, and more preferably 0.00005% by mass or more with respect to the entire oral composition (100% by mass). Is. As a result, the effect of suppressing the feeling of convergence and the effect of sustaining the feeling of convergence can be exerted.
- the upper limit is usually 0.5% by mass or less, more preferably 0.1% by mass or less, still more preferably 0.01% by mass or less, still more preferably 0.005% by mass or less.
- the content of the component (B) is usually 0.000001 to 0.5% by mass, preferably 0.00001 to 0.1% by mass, and more preferably 0.00001 to 0.01% by mass. More preferably, it is 0.00005 to 0.005% by mass.
- the component (C) is a nonionic surfactant. By containing the component (C), it is possible to impart an effect of suppressing a feeling of convergence to the oral composition.
- nonionic surfactant examples include polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester (eg, polyoxyethylene sorbitan monostearate), alkyrrole amide, and polyoxy.
- Ethylene fatty acid esters polyoxyethylene alkenyl ethers, polyglycerin fatty acid esters, sucrose fatty acid esters (eg, maltose fatty acid esters), sugar alcohol fatty acid esters (eg, multitoll fatty acid esters, lactitol fatty acid esters), fatty acid diethanolamides (eg,) (Lauric acid mono or diethanolamide), polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, and the like.
- the number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is usually 14 to 18, and the average number of moles of ethylene oxide added is usually 15 to 30 mol.
- the average number of moles of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is usually 20 to 100 mol, preferably 20 to 60 mol.
- the number of carbon atoms of the fatty acid of the sorbitan fatty acid ester is usually 12 to 18.
- the number of carbon atoms of the fatty acid of the polyoxyethylene sorbitan fatty acid ester is usually 16 to 18, and the average number of moles of ethylene oxide added is usually 10 to 40 mol.
- the number of carbon atoms in the alkyl chain of the alkylolamide is usually 12 to 14.
- the nonionic surfactant polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl ether and polyglycerin fatty acid ester are preferable.
- the content of the component (C) is usually 0.01% by mass or more, preferably 0.1% by mass or more, more preferably 0.3% by mass, based on the entire oral composition (100% by mass). That is all. This makes it possible to impart a good effect of suppressing a feeling of convergence.
- the upper limit is usually 5% by mass or less, preferably 1% by mass or less, and more preferably 0.8% by mass or less. This makes it possible to suppress a decrease in refreshing feeling and a decrease in flavor expression. Therefore, the content of the component (C) is usually 0.01 to 5% by mass, preferably 0.1 to 1% by mass, more preferably 0.3 to 1% by mass, and further preferably 0.3. It is about 0.8% by mass.
- the oral composition of the present embodiment may contain arbitrary components other than the components (A) to (C) already described, as long as the effects of the present invention are not impaired.
- the optional component examples include a surfactant, a sweetener, a fragrance, a medicinal component, an oily component, an abrasive, a preservative, a wetting agent, a binder, a pH adjuster, a colorant (dye), and a solvent.
- a surfactant e.g., a surfactant, a sweetener, a fragrance, a medicinal component, an oily component, an abrasive, a preservative, a wetting agent, a binder, a pH adjuster, a colorant (dye), and a solvent.
- the abrasive may be either an inorganic abrasive or an organic abrasive.
- the inorganic abrasive include abrasive silica such as precipitate silica, aluminosilicate, zirconosilicate, crystalline zirconium silicate, and titanium-binding silica; calcium dibasic phosphate / dihydrate or anhydrous, calcium primary phosphate.
- Calcium phosphate-based compounds such as tertiary calcium phosphate and calcium pyrophosphate
- calcium carbonate-based abrasives such as calcium carbonate
- calcium-based abrasives other than carbonic acid / phosphoric acid such as calcium hydroxide and calcium sulfate
- aluminum oxide, aluminum hydroxide, Aluminum-based materials such as alumina
- Silica-based materials such as silicic acid anhydride, zeolite, and zirconium silicate
- Magnesium-based materials such as magnesium carbonate and tertiary magnesium phosphate
- Apatite-based materials such as hydroxyapatite, fluoroapatite, and calcium-deficient apatite.
- Titanium-based materials such as titanium dioxide, mica titanium, and titanium oxide; minerals such as bentonite can be mentioned.
- organic abrasive include polymethylmethacrylate and synthetic resin-based abrasives. Of these, a silica-based abrasive is preferable.
- the content of the abrasive is usually 70% by mass or less, preferably 50% by mass or less, and more preferably 8 to 50% by mass with respect to the entire oral composition (100% by mass).
- surfactant other than the component (C) examples include an anionic surfactant, an amphoteric surfactant, and a cationic surfactant.
- anionic surfactant examples include alkyl sulfates, acyl amino acid salts, acyl taurine salts, ⁇ -olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfates, and lauryl sulfoacetates.
- the alkyl group and the acyl group may be either a straight chain or a branched chain, and may be saturated or unsaturated, and the number of carbon atoms thereof is usually 10 to 20, preferably 12 to 18, and more preferably 12 to 18. It is 14.
- the salt can be selected from pharmacologically acceptable salts.
- Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts.
- inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt
- organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt
- arginine salt and the like Basic amino acid salts of.
- inorganic base salts are preferred, alkali metal salts (eg, sodium salts, potassium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
- alkyl sulfate examples include lauryl sulfate (sodium lauryl sulfate) and myristyl sulfate.
- acyl amino acid salt examples include acyl sarcosine salts such as lauroyl sarcosin salt and myristoyl sarcosin salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycine salt and cocoyl glycine.
- Acylglycine salts such as salts; N-lauroyl- ⁇ -alanine salt, N-myristyl- ⁇ -alanine salt, N-cocoyl- ⁇ -alanine salt, N-lauroyl-N-methyl- ⁇ -alanine salt, N-myristoyl Acylalanine salts such as -N-methyl- ⁇ -alanine salt, N-methyl-N-acylalanine salt; acylasparaginate such as lauroyl asparagate can be mentioned.
- the acyl taurine salt include lauroylmethyl taurine salt, N-methyl-N-acyl taurine salt, and N-cocoyl methyl taurine salt.
- ⁇ -olefin sulfonate examples include ⁇ -olefin sulfonates having 12 to 18 carbon atoms such as tetradecene sulfonate.
- anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
- the anionic surfactant preferably contains a sulfonic acid group in terms of foaming and good foam quality, and more preferably an alkyl sulfate or an ⁇ -olefin sulfonate.
- amphoteric surfactant examples include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine) and fatty acid amide propyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); N-.
- alkyldimethylaminoacetic acid betaine eg, lauryldimethylaminoacetic acid betaine
- fatty acid amide propyldimethylaminoacetic acid betaine eg, cocamidopropyl betaine
- Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salt eg, N-palm oil fatty acid acyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine), coconut oil fatty acid imidazolinium betaine, 2-alkyl
- imidazoline-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine
- alkyl betaines such as lauryldimethylaminoacetic acid betaine.
- the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
- Examples of the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
- the content of the surfactant is preferably 0.1 to 3% by mass, more preferably 0.6 to 2.5% by mass, based on the entire oral composition (100% by mass). , More preferably 1 to 2.5% by mass.
- sugar alcohols and polyhydric alcohols other than sugar alcohols are preferable.
- sugar alcohol include sugar alcohols such as sorbitol, erythritol, martitol, lactitol, xylitol, and reduced starch saccharified; glycerin; polyhydric alcohols such as ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, and polyethylene glycol.
- polyethylene glycol include polyethylene glycol having an average molecular weight of 150 to 6000, and polyethylene glycol having an average molecular weight of 190 to 630 is preferable. Specific examples thereof include PEG200, PEG300, PEG400 and PEG600.
- the content of the wetting agent is usually 40% by mass or less, preferably 1 to 30% by mass, based on the entire oral composition (100% by mass).
- the average molecular weight is the average molecular weight described in the Quasi-drug Raw Material Standard 2006.
- the medicinal ingredient examples include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timol, hinokithiol, and lysoteam chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ⁇ -aminocaproic acid, allantin, tranexamic acid, glycyrrhizinate (eg, glycyrrhetin dipotassium salt) ), Anti-inflammatory agents such as glycyrrhetinic acid, glycyrrhetinate (eg, stearyl glycyrrhetinate), allantinchlorhydroxya
- the medicinal ingredient may be used alone or in combination of two or more.
- the content of the medicinal ingredient can be appropriately set as an effective amount according to a conventional method.
- fragrances include peppermint oil, sparemint oil, Japanese peppermint oil, anis oil, cassia oil, eucalyptus oil, winter green oil, mastic oil, neroli oil (orange flower oil), lemongrass oil, jasmine oil, and rose oil.
- Iris oil clove oil, thyme oil, sage oil, cardamon oil, rosemary oil, laurel oil, chamomil oil, caraway oil, basil oil, majorum oil, lemon oil, orange oil, lime oil, yuzu oil, nutmeg oil , Lavender oil, Paracres oil, Vanilla oil, Katsura skin oil, Pimento oil, Katsura leaf oil, Perilla oil, Winter green oil and other natural essential oils; , Timor, linalol, limonen, menton, mentylacetate, citral, decanal, camphor, borneol, pinen, spirantol, n-decyl alcohol, citronellol, ⁇ -terpineol, citronellyl acetate, cineole, ethyllinalol, varnish and other natural essential oils.
- fragrance components contained in such as ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methyl phenylglycidate, benzaldehyde, vanillin, ethyl vaniline, flaneol; and some fragrances.
- fragrance components such as ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methyl phenylglycidate, benzaldehyde, vanillin, ethyl vaniline, flaneol; and some fragrances.
- examples include various blended flavors such as mint-based, fruit-based, and herbal-based, which are a combination of ingredients and natural essential oils.
- the above-exemplified fragrance may be used alone or in combination of
- the feeling of use can be further improved.
- the sweetener include saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, aspartylphenylalanine methyl ester and the like.
- the above-exemplified sweetener may be used alone or in combination of two or more.
- oily component examples include hydrocarbons such as squalane, liquid paraffin, vaseline, and microcrystalin wax; and having 8 carbon atoms such as higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, and isostearyl alcohol). ⁇ 22 alcohols); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), vegetable oils such as olive oil, castor oil, palm oil; Examples include fatty acid esters.
- the antiseptic power of the preparation can be ensured.
- the preservative include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like.
- the preservative may be used alone or in combination of two or more.
- any suitable organic binder conventionally known for example, a polysaccharide, a cellulosic binder (for example, carboxymethyl cellulose (CMC), hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, cation) Celluloseized cellulose, etc.), other polysaccharide thickeners (eg, xanthan gum, gua gum, gellan gum, tragant gum, karaya gum, arabiya gum, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (eg, sodium polyacrylate, etc.) Cardovinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, propylene glycol alginate) can be mentioned.
- CMC carboxymethyl cellulose
- hydroxyethyl cellulose hydroxypropyl cellulose
- hydroxypropylmethyl cellulose hydroxypropylmethyl cellulose
- methyl cellulose c
- an inorganic binder such as thickening silica and aluminum silicate can be blended.
- the content of any organic binder is preferably 0 to 3% by mass, more preferably 0.1 to 2% by mass, based on the entire oral composition (100% by mass).
- the content of the inorganic binder is preferably 0 to 10% by mass, more preferably 1 to 8% by mass.
- the pH stability of the pharmaceutical product can be ensured.
- the pH adjuster include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid and lactic acid, or salts thereof (sodium citrate) and inorganic acids such as phosphoric acid (orthoric acid). Acids or hydroxides thereof such as salts thereof (eg, potassium salt, sodium salt and ammonium salt), sodium hydroxide, potassium hydroxide and the like can be mentioned.
- the inorganic acid salt include disodium hydrogen phosphate and sodium dihydrogen phosphate.
- the content of the pH adjuster can usually be such that the pH of the oral composition after addition is 5 to 9, preferably 6 to 8.5.
- the pH value usually means a value at 25 ° C. and 3 minutes after the start of measurement.
- the pH value can be measured using, for example, a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
- the colorant examples include natural pigments such as Benibana red pigment, Kuchinashi yellow element, Kuchinashi blue pigment, perilla pigment, red koji pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, and tamarind pigment.
- Legal dyes such as Red No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, Blue No. 1, Riboflavin, Copper Chlorophine Sodium , Titanium dioxide and the like.
- the content thereof is preferably 0.00001 to 3% by mass with respect to the entire oral composition.
- the solvent examples include water (purified water), ethanol and the like, and water is preferable.
- water purified water
- ethanol ethanol
- water is preferable.
- the solvent one type may be used alone or two or more types may be used in combination.
- optional ingredients examples include polyisobutylene, polybutadiene, urethane, silicon, and natural rubber.
- the content of these other optional components can be appropriately set as long as the effect of the present invention is not impaired.
- the oral composition of the present invention can be an oral preparation such as a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
- the dosage form of the oral composition can be appropriately selected depending on the usage form, and is not particularly limited.
- the dosage form is, for example, in the form of a paste or liquid, and if it is a dentifrice, it can be prepared as a dentifrice, a liquid dentifrice, a liquid dentifrice, or a dentifrice.
- the method for producing the oral composition is not particularly limited, and can be prepared by each usual method depending on the dosage form.
- a method of preparing a component that dissolves in a solvent, mixing other insoluble components, and defoaming (for example, reducing the pressure) as necessary can be mentioned.
- the obtained toothpaste can be contained in a container and made into a product.
- the shape and material of the container are not particularly limited, and a container used for a normal dentifrice composition can be used.
- a container such as a plastic laminated tube such as polyethylene, polypropylene, polyethylene terephthalate, or nylon can be used. Be done.
- Abrasive silica Tixosil (registered trademark) 73 (manufactured by Solvay) Sodium fluoride: (manufactured by Stella Chemipha Co., Ltd.) Sodium lauryl sulfate: (manufactured by BASF) Sorbitol liquid (70%): (manufactured by Mitsubishi Corporation Life Science Co., Ltd.) Propylene glycol: (manufactured by ADEKA) Viscous silica: Carplex (registered trademark) # 67 (manufactured by DSL Japan Co., Ltd.) Saccharin sodium: (manufactured by Aisan Chemical Industry Co., Ltd.) Water (purified water) For ingredients other than the above, raw materials conforming to the quasi-drug raw material standard 2006 were used.
- ⁇ Refreshing feeling> Regarding the refreshing feeling, the refreshing feeling was evaluated depending on the presence or absence of stickiness in the oral cavity after rinsing the oral cavity with water after brushing the teeth. Rating criteria 4 points: Very refreshing feeling 3 points: Feeling refreshing feeling 2 points: Not feeling refreshing feeling 1 point: Feeling refreshing feeling Evaluation criteria Excellent: Average score 3.5 points or more 4.0 points or less Good: Average score 3.0 points or more and less than 3.5 points Possible: Average score 2.0 points or more and less than 3.0 points Impossible: Average score less than 2.0 points
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
The purpose of the present invention is to provide a composition for an oral cavity, such as toothpaste, that makes it possible to obtain a refreshing feeling, is capable of inhibiting an astringent feeling, and is capable of maintaining the inhibitory effect of the astringent feeling. The present invention provides a composition for an oral cavity containing (A) one or more compounds selected from the group consisting of carbonates, bicarbonates, sulfates and chlorides, and (B) one or more compounds selected from the group consisting of N–(2–hydroxy–2–phenylethyl)–2–isopropyl–5,5–dimethylcyclohexane–1–carboxamide, ethyl–3–(p–menthane–3–carboxamide)acetate, and N–(2–(2–pyridinyl)ethyl)–2–isopropyl–5–methylcyclohexanecarboxamide.
Description
本発明は、口腔用組成物に関する。
The present invention relates to an oral composition.
歯磨剤等の口腔用組成物には、通常、研磨剤、界面活性剤、湿潤剤、粘結剤等が配合され、界面活性剤としてノニオン性界面活性剤等が泡立ち、清掃性等の確保のために用いられている。また、研磨剤等による物理的な清掃実感だけでなく、炭酸水素ナトリウムやその他の塩類を加えることによって口腔内のネバツキを除去してサッパリ感を付与する方法が公知化されている。しかしながら、炭酸水素ナトリウムやその他塩類にはサッパリ感とともに収斂味や特有の嫌味、刺激等があり課題であった。
Oral compositions such as dentifrices are usually blended with abrasives, surfactants, wetting agents, binders and the like, and nonionic surfactants and the like foam as surfactants to ensure cleanability and the like. Is used for. Further, a method of removing stickiness in the oral cavity and giving a refreshing feeling by adding sodium hydrogen carbonate or other salts has been publicized as well as a physical cleaning feeling with an abrasive or the like. However, sodium hydrogen carbonate and other salts have a refreshing feeling as well as a convergent taste, a peculiar sarcasm, and irritation, which have been problems.
特許文献1には、炭酸水素ナトリウムとラウリル硫酸ナトリウムを併用した口腔用組成物に、特定のアミドベタイン型両性活性剤を配合することにより、サッパリ感は維持しつつ粘膜刺激を緩和できたことが記載されている。特許文献2には、炭酸水素塩等を含む口腔用組成物に、グリシン、アラニン、ロイシン、グルタミン酸及びそれらの塩を加えることにより、炭酸水素ナトリウムによる収斂性の発現が抑制されることが記載されている。特許文献3には、重曹等の収斂性を有する化合物を含む口腔用組成物に、ラノリン及びその誘導体、鯨ロウ、カルナウバロウ、カンデリラロウ、ミツロウから選ばれる1種又は2種以上のロウ類を配合することにより、炭酸水素ナトリウムの収斂味を改善できることが記載されている。
Patent Document 1 states that by blending a specific amide betaine-type amphoteric tenside into an oral composition using sodium hydrogen carbonate and sodium lauryl sulfate in combination, mucosal irritation could be alleviated while maintaining a refreshing feeling. Have been described. Patent Document 2 describes that the development of astringency by sodium hydrogen carbonate is suppressed by adding glycine, alanine, leucine, glutamic acid and salts thereof to an oral composition containing a hydrogen carbonate or the like. ing. Patent Document 3 contains one or more waxes selected from lanolin and its derivatives, whale wax, carnauba wax, candelilla wax, and beeswax in an oral composition containing a converging compound such as baking soda. It is described that this can improve the astringency of sodium hydrogen carbonate.
しかし、特許文献1の技術では、収斂味(収斂感)の改善には不十分である。また、特許文献2及び3の技術も収斂味の抑制には不十分であり、収斂味の抑制効果の持続性の面でも改善の余地がある。収斂味(収斂感)は、特に若年層には違和感に繋がることがあり、抑制手段の開発が期待されている。
本発明の目的は、口腔内のネバツキが解消されサッパリ感(爽快感)を得ることができ、収斂感を抑制でき、かつ収斂感の抑制効果を持続させることができる、口腔用組成物を提供することにある。 However, the technique of Patent Document 1 is insufficient for improving the convergent taste (convergent feeling). Further, the techniques of Patent Documents 2 and 3 are also insufficient for suppressing the astringent taste, and there is room for improvement in terms of the sustainability of the astringent taste suppressing effect. Convergence (convergence) may lead to discomfort, especially for young people, and the development of means for suppressing it is expected.
An object of the present invention is to provide an oral composition capable of eliminating stickiness in the oral cavity, obtaining a refreshing feeling (exhilarating feeling), suppressing a feeling of convergence, and sustaining the effect of suppressing the feeling of convergence. To do.
本発明の目的は、口腔内のネバツキが解消されサッパリ感(爽快感)を得ることができ、収斂感を抑制でき、かつ収斂感の抑制効果を持続させることができる、口腔用組成物を提供することにある。 However, the technique of Patent Document 1 is insufficient for improving the convergent taste (convergent feeling). Further, the techniques of Patent Documents 2 and 3 are also insufficient for suppressing the astringent taste, and there is room for improvement in terms of the sustainability of the astringent taste suppressing effect. Convergence (convergence) may lead to discomfort, especially for young people, and the development of means for suppressing it is expected.
An object of the present invention is to provide an oral composition capable of eliminating stickiness in the oral cavity, obtaining a refreshing feeling (exhilarating feeling), suppressing a feeling of convergence, and sustaining the effect of suppressing the feeling of convergence. To do.
すなわち、本発明は、以下の〔1〕~〔8〕を提供する。
〔1〕(A)炭酸塩、炭酸水素塩、硫酸塩、及び塩化物からなる群より選ばれる1種以上、及び
(B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド、エチル-3-(p-メンタン-3-カルボキサミド)アセテート、及びN-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドからなる群より選ばれる1種以上を含有する口腔用組成物(但し、(A)硫酸ナトリウム及び(B)エチル-3-(p-メンタン-3-カルボキサミド)アセテートを含有する歯磨剤組成物を除く)。
〔2〕以下の少なくともいずれか1つを満たす、〔1〕に記載の口腔用組成物:
炭酸塩が、炭酸ナトリウム、炭酸カリウム、及び炭酸マグネシウムからなる群より選ばれる1種以上であること;
炭酸水素塩が、炭酸水素ナトリウム、炭酸水素カリウム、炭酸水素カルシウム、及び炭酸水素マグネシウムからなる群より選ばれる1種以上であること;
硫酸塩が、硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸アルミニウムカリウム、硫酸アルミニウムナトリウム、及び硫酸アルミニウムアンモニウムからなる群より選ばれる1種以上であること;及び
塩化物が、塩化ナトリウム、塩化カリウム、及び塩化マグネシウムからなる群より選ばれる1種以上であること。
〔3〕(A)成分の含有量が、0.1~10質量%である、〔1〕又は〔2〕に記載の口腔用組成物。
〔4〕(B)成分の含有量が、0.00001~0.1質量%である、〔1〕~〔3〕のいずれか1項に記載の口腔用組成物。
〔5〕(C):ノニオン性界面活性剤をさらに含有する、〔1〕~〔4〕のいずれか1項に記載の口腔用組成物。
〔6〕(C)成分が、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテル及びポリグリセリン脂肪酸エステルからなる群より選ばれる1種以上を含む、〔5〕に記載の口腔用組成物。
〔7〕(C)成分の含有量が、0.1~1質量%である、〔5〕又は〔6〕に記載の口腔用組成物。
〔8〕歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤である〔1〕~〔7〕のいずれか1項に記載の口腔用組成物。 That is, the present invention provides the following [1] to [8].
[1] One or more selected from the group consisting of (A) carbonate, hydrogen carbonate, sulfate, and chloride, and (B) N- (2-hydroxy-2-phenylethyl) -2-isopropyl-. From 5,5-dimethylcyclohexane-1-carboxamide, ethyl-3- (p-menthan-3-carboxamide) acetate, and N- (2- (2-pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide Oral compositions containing one or more selected from the above group (excluding (A) sodium sulfate and (B) dentin composition containing ethyl-3- (p-menthan-3-carboxamide) acetate. ).
[2] The oral composition according to [1], which satisfies at least one of the following:
The carbonate is at least one selected from the group consisting of sodium carbonate, potassium carbonate, and magnesium carbonate;
Bicarbonate is at least one selected from the group consisting of sodium hydrogen carbonate, potassium hydrogen carbonate, calcium hydrogen carbonate, and magnesium hydrogen carbonate;
The sulfate is at least one selected from the group consisting of sodium sulfate, potassium sulfate, magnesium sulfate, potassium aluminum sulfate, sodium aluminum sulfate, and ammonium aluminum sulfate; and the chloride is sodium chloride, potassium chloride, and At least one selected from the group consisting of magnesium chloride.
[3] The oral composition according to [1] or [2], wherein the content of the component (A) is 0.1 to 10% by mass.
[4] The oral composition according to any one of [1] to [3], wherein the content of the component (B) is 0.00001 to 0.1% by mass.
[5] (C): The oral composition according to any one of [1] to [4], further containing a nonionic surfactant.
[6] The oral composition according to [5], wherein the component (C) contains at least one selected from the group consisting of polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether and polyglycerin fatty acid ester.
[7] The oral composition according to [5] or [6], wherein the content of the component (C) is 0.1 to 1% by mass.
[8] The oral composition according to any one of [1] to [7], which is a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
〔1〕(A)炭酸塩、炭酸水素塩、硫酸塩、及び塩化物からなる群より選ばれる1種以上、及び
(B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド、エチル-3-(p-メンタン-3-カルボキサミド)アセテート、及びN-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドからなる群より選ばれる1種以上を含有する口腔用組成物(但し、(A)硫酸ナトリウム及び(B)エチル-3-(p-メンタン-3-カルボキサミド)アセテートを含有する歯磨剤組成物を除く)。
〔2〕以下の少なくともいずれか1つを満たす、〔1〕に記載の口腔用組成物:
炭酸塩が、炭酸ナトリウム、炭酸カリウム、及び炭酸マグネシウムからなる群より選ばれる1種以上であること;
炭酸水素塩が、炭酸水素ナトリウム、炭酸水素カリウム、炭酸水素カルシウム、及び炭酸水素マグネシウムからなる群より選ばれる1種以上であること;
硫酸塩が、硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸アルミニウムカリウム、硫酸アルミニウムナトリウム、及び硫酸アルミニウムアンモニウムからなる群より選ばれる1種以上であること;及び
塩化物が、塩化ナトリウム、塩化カリウム、及び塩化マグネシウムからなる群より選ばれる1種以上であること。
〔3〕(A)成分の含有量が、0.1~10質量%である、〔1〕又は〔2〕に記載の口腔用組成物。
〔4〕(B)成分の含有量が、0.00001~0.1質量%である、〔1〕~〔3〕のいずれか1項に記載の口腔用組成物。
〔5〕(C):ノニオン性界面活性剤をさらに含有する、〔1〕~〔4〕のいずれか1項に記載の口腔用組成物。
〔6〕(C)成分が、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテル及びポリグリセリン脂肪酸エステルからなる群より選ばれる1種以上を含む、〔5〕に記載の口腔用組成物。
〔7〕(C)成分の含有量が、0.1~1質量%である、〔5〕又は〔6〕に記載の口腔用組成物。
〔8〕歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤である〔1〕~〔7〕のいずれか1項に記載の口腔用組成物。 That is, the present invention provides the following [1] to [8].
[1] One or more selected from the group consisting of (A) carbonate, hydrogen carbonate, sulfate, and chloride, and (B) N- (2-hydroxy-2-phenylethyl) -2-isopropyl-. From 5,5-dimethylcyclohexane-1-carboxamide, ethyl-3- (p-menthan-3-carboxamide) acetate, and N- (2- (2-pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide Oral compositions containing one or more selected from the above group (excluding (A) sodium sulfate and (B) dentin composition containing ethyl-3- (p-menthan-3-carboxamide) acetate. ).
[2] The oral composition according to [1], which satisfies at least one of the following:
The carbonate is at least one selected from the group consisting of sodium carbonate, potassium carbonate, and magnesium carbonate;
Bicarbonate is at least one selected from the group consisting of sodium hydrogen carbonate, potassium hydrogen carbonate, calcium hydrogen carbonate, and magnesium hydrogen carbonate;
The sulfate is at least one selected from the group consisting of sodium sulfate, potassium sulfate, magnesium sulfate, potassium aluminum sulfate, sodium aluminum sulfate, and ammonium aluminum sulfate; and the chloride is sodium chloride, potassium chloride, and At least one selected from the group consisting of magnesium chloride.
[3] The oral composition according to [1] or [2], wherein the content of the component (A) is 0.1 to 10% by mass.
[4] The oral composition according to any one of [1] to [3], wherein the content of the component (B) is 0.00001 to 0.1% by mass.
[5] (C): The oral composition according to any one of [1] to [4], further containing a nonionic surfactant.
[6] The oral composition according to [5], wherein the component (C) contains at least one selected from the group consisting of polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether and polyglycerin fatty acid ester.
[7] The oral composition according to [5] or [6], wherein the content of the component (C) is 0.1 to 1% by mass.
[8] The oral composition according to any one of [1] to [7], which is a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
本発明によれば、口腔内のネバツキが解消されサッパリ感を得ることができ、収斂感を抑制でき、かつ収斂感の抑制効果を持続させることができる、口腔用組成物を提供することができる。
According to the present invention, it is possible to provide an oral composition capable of eliminating stickiness in the oral cavity, obtaining a refreshing feeling, suppressing a feeling of convergence, and sustaining the effect of suppressing the feeling of convergence. ..
以下、本発明について詳細に説明する。
本発明の口腔用組成物は、下記(A)及び(B)成分を含有し、好ましくは(C)成分を更に含有する。 Hereinafter, the present invention will be described in detail.
The oral composition of the present invention contains the following components (A) and (B), and preferably further contains the component (C).
本発明の口腔用組成物は、下記(A)及び(B)成分を含有し、好ましくは(C)成分を更に含有する。 Hereinafter, the present invention will be described in detail.
The oral composition of the present invention contains the following components (A) and (B), and preferably further contains the component (C).
[(A)成分]
(A)成分は、炭酸塩、炭酸水素塩、硫酸塩、及び塩化物からなる群より選ばれる1種以上である。(A)成分を含有することにより、口腔用組成物にサッパリ感を付与できる。(B)成分がエチル-3-(p-メンタン-3-カルボキサミド)アセテートである場合、(A)成分は、硫酸ナトリウム以外、すなわち、炭酸塩、炭酸水素塩、硫酸アルミニウム塩及び塩化物からなる群より選ばれる1種以上である。 [(A) component]
The component (A) is at least one selected from the group consisting of carbonates, bicarbonates, sulfates, and chlorides. By containing the component (A), a refreshing feeling can be imparted to the oral composition. When the component (B) is ethyl-3- (p-menthan-3-carboxamide) acetate, the component (A) consists of other than sodium sulfate, that is, carbonate, bicarbonate, aluminum sulfate and chloride. One or more species selected from the group.
(A)成分は、炭酸塩、炭酸水素塩、硫酸塩、及び塩化物からなる群より選ばれる1種以上である。(A)成分を含有することにより、口腔用組成物にサッパリ感を付与できる。(B)成分がエチル-3-(p-メンタン-3-カルボキサミド)アセテートである場合、(A)成分は、硫酸ナトリウム以外、すなわち、炭酸塩、炭酸水素塩、硫酸アルミニウム塩及び塩化物からなる群より選ばれる1種以上である。 [(A) component]
The component (A) is at least one selected from the group consisting of carbonates, bicarbonates, sulfates, and chlorides. By containing the component (A), a refreshing feeling can be imparted to the oral composition. When the component (B) is ethyl-3- (p-menthan-3-carboxamide) acetate, the component (A) consists of other than sodium sulfate, that is, carbonate, bicarbonate, aluminum sulfate and chloride. One or more species selected from the group.
炭酸塩としては、例えば、炭酸ナトリウム、炭酸カリウム、炭酸マグネシウムが挙げられる。炭酸水素塩としては、例えば、炭酸水素ナトリウム、炭酸水素カリウム、炭酸水素カルシウム、炭酸水素マグネシウムが挙げられる。硫酸塩としては、例えば、硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸アルミニウム、ミョウバンが挙げられる。ミョウバンとしては、例えば、硫酸アルミニウムカリウム、硫酸アルミニウムナトリウム、硫酸アルミニウムアンモニウムが挙げられる。塩化物としては、例えば、塩化ナトリウム、塩化カリウム、塩化マグネシウムが挙げられる。これらの中では、炭酸水素ナトリウム、塩化ナトリウム、硫酸アルミニウムカリウムが好ましい。(A)成分は、1種でも2種以上の組み合わせでもよい。
Examples of the carbonate include sodium carbonate, potassium carbonate, and magnesium carbonate. Examples of the hydrogen carbonate include sodium hydrogen carbonate, potassium hydrogen carbonate, calcium hydrogen carbonate, and magnesium hydrogen carbonate. Examples of the sulfate include sodium sulfate, potassium sulfate, magnesium sulfate, aluminum sulfate, and alum. Examples of alum include potassium aluminum sulfate, sodium aluminum sulfate, and ammonium aluminum sulfate. Examples of the chloride include sodium chloride, potassium chloride and magnesium chloride. Among these, sodium hydrogen carbonate, sodium chloride, and potassium aluminum sulfate are preferable. The component (A) may be one kind or a combination of two or more kinds.
(A)成分の含有量は、口腔用組成物全体(100質量%)に対し、通常、0.05質量%以上、好ましくは、0.1質量%以上、より好ましくは0.2質量%以上である。これにより、サッパリ感を付与できる。上限は、通常、20質量%以下、好ましくは、10質量%以下、より好ましくは、5質量%以下である。これにより、収斂感の発現を抑制できる。従って、(A)成分の含有量は、通常、0.05~20質量%、好ましくは、0.1~10質量%、より好ましくは0.2~10質量%、更に好ましくは0.2~5質量%である。
The content of the component (A) is usually 0.05% by mass or more, preferably 0.1% by mass or more, more preferably 0.2% by mass or more, based on the entire oral composition (100% by mass). Is. This can give a refreshing feeling. The upper limit is usually 20% by mass or less, preferably 10% by mass or less, and more preferably 5% by mass or less. This makes it possible to suppress the development of a feeling of convergence. Therefore, the content of the component (A) is usually 0.05 to 20% by mass, preferably 0.1 to 10% by mass, more preferably 0.2 to 10% by mass, and further preferably 0.2 to 0.2 to 10% by mass. It is 5% by mass.
[(B)成分]
(B)成分は、N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド、エチル-3-(p-メンタン-3-カルボキサミド)アセテート及びN-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドからなる群より選ばれる1種以上である。(B)成分を含有することにより、口腔用組成物に収斂感の抑制とその持続性を付与できる。本明細書において「収斂感」とは、歯ぐきがきゅっと引き締まる感覚を意味し、刺激(単なる痛み)とは区別される。 [(B) component]
The components (B) are N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide, ethyl-3- (p-menthane-3-carboxamide) acetate and N. -(2- (2-Pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexane Carboxamide is one or more selected from the group. By containing the component (B), it is possible to suppress the feeling of convergence and impart its sustainability to the oral composition. As used herein, the term "convergence" means the sensation of tightness in the gums and is distinguished from irritation (simply pain).
(B)成分は、N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド、エチル-3-(p-メンタン-3-カルボキサミド)アセテート及びN-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドからなる群より選ばれる1種以上である。(B)成分を含有することにより、口腔用組成物に収斂感の抑制とその持続性を付与できる。本明細書において「収斂感」とは、歯ぐきがきゅっと引き締まる感覚を意味し、刺激(単なる痛み)とは区別される。 [(B) component]
The components (B) are N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide, ethyl-3- (p-menthane-3-carboxamide) acetate and N. -(2- (2-Pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexane Carboxamide is one or more selected from the group. By containing the component (B), it is possible to suppress the feeling of convergence and impart its sustainability to the oral composition. As used herein, the term "convergence" means the sensation of tightness in the gums and is distinguished from irritation (simply pain).
(B)成分は、1種でも2種以上の組み合わせでもよいが、N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド及びN-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドを少なくとも含むことが好ましい。これにより、より良好な収斂感の抑制効果とその持続効果を付与できる。さらに、N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミドを少なくとも含むことがより好ましい。これにより、収斂感の抑制効果をより持続させることができ、またより良好なサッパリ感を付与できる。
The component (B) may be one kind or a combination of two or more kinds, but N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide and N- (2). -(2-Pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide is preferably contained. As a result, it is possible to impart a better effect of suppressing the feeling of convergence and an effect of sustaining the effect. Further, it is more preferable to contain at least N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide. As a result, the effect of suppressing the feeling of convergence can be further sustained, and a better feeling of refreshment can be imparted.
(B)成分の含有量は、口腔用組成物全体(100質量%)に対し、通常、0.000001質量%以上、好ましくは、0.00001質量%以上、より好ましくは0.00005質量%以上である。これにより、収斂感の抑制効果及び収斂感の抑制持続効果を発揮できる。上限は、通常、0.5質量%以下、より好ましくは、0.1質量%以下、更に好ましくは、0.01質量%以下、更により好ましくは、0.005質量%以下である。これにより、口腔内への刺激発現、香味発現性の低下を抑制できる。従って、(B)成分の含有量は、通常、0.000001~0.5質量%、好ましくは、0.00001~0.1質量%、より好ましくは、0.00001~0.01質量%、更に好ましくは0.00005~0.005質量%である。
The content of the component (B) is usually 0.000001% by mass or more, preferably 0.00001% by mass or more, and more preferably 0.00005% by mass or more with respect to the entire oral composition (100% by mass). Is. As a result, the effect of suppressing the feeling of convergence and the effect of sustaining the feeling of convergence can be exerted. The upper limit is usually 0.5% by mass or less, more preferably 0.1% by mass or less, still more preferably 0.01% by mass or less, still more preferably 0.005% by mass or less. As a result, it is possible to suppress the expression of irritation in the oral cavity and the decrease in flavor expression. Therefore, the content of the component (B) is usually 0.000001 to 0.5% by mass, preferably 0.00001 to 0.1% by mass, and more preferably 0.00001 to 0.01% by mass. More preferably, it is 0.00005 to 0.005% by mass.
[(C)成分]
(C)成分は、ノニオン界面活性剤である。(C)成分を含有することにより、口腔用組成物に収斂感の抑制効果を付与できる。 [(C) component]
The component (C) is a nonionic surfactant. By containing the component (C), it is possible to impart an effect of suppressing a feeling of convergence to the oral composition.
(C)成分は、ノニオン界面活性剤である。(C)成分を含有することにより、口腔用組成物に収斂感の抑制効果を付与できる。 [(C) component]
The component (C) is a nonionic surfactant. By containing the component (C), it is possible to impart an effect of suppressing a feeling of convergence to the oral composition.
ノニオン界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル(例、ポリオキシエチレンソルビタンモノステアレート)、アルキロールアミド、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンアルケニルエーテル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル(例、マルトース脂肪酸エステル)、糖アルコール脂肪酸エステル(例、マルチトール脂肪酸エステル、ラクチトール脂肪酸エステル)、脂肪酸ジエタノールアミド(例、ラウリル酸モノ又はジエタノールアミド)、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンポリオキシプロピレン脂肪酸エステルが挙げられる。ポリオキシエチレンアルキルエーテルのアルキル鎖の炭素原子数は、通常、14~18であり、エチレンオキサイド平均付加モル数は、通常、15~30モルである。ポリオキシエチレン硬化ヒマシ油のエチレンオキサイド平均付加モル数は、通常20~100モル、好ましくは20~60モルである。ソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常12~18である。ポリオキシエチレンソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常16~18であり、エチレンオキサイド平均付加モル数は、通常10~40モルである。アルキロールアミドのアルキル鎖の炭素原子数は、通常12~14である。ノニオン界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテル及びポリグリセリン脂肪酸エステルが好ましい。
Examples of the nonionic surfactant include polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester (eg, polyoxyethylene sorbitan monostearate), alkyrrole amide, and polyoxy. Ethylene fatty acid esters, polyoxyethylene alkenyl ethers, polyglycerin fatty acid esters, sucrose fatty acid esters (eg, maltose fatty acid esters), sugar alcohol fatty acid esters (eg, multitoll fatty acid esters, lactitol fatty acid esters), fatty acid diethanolamides (eg,) (Lauric acid mono or diethanolamide), polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, and the like. The number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is usually 14 to 18, and the average number of moles of ethylene oxide added is usually 15 to 30 mol. The average number of moles of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is usually 20 to 100 mol, preferably 20 to 60 mol. The number of carbon atoms of the fatty acid of the sorbitan fatty acid ester is usually 12 to 18. The number of carbon atoms of the fatty acid of the polyoxyethylene sorbitan fatty acid ester is usually 16 to 18, and the average number of moles of ethylene oxide added is usually 10 to 40 mol. The number of carbon atoms in the alkyl chain of the alkylolamide is usually 12 to 14. As the nonionic surfactant, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl ether and polyglycerin fatty acid ester are preferable.
(C)成分の含有量は、口腔用組成物全体(100質量%)に対し、通常、0.01質量%以上、好ましくは、0.1質量%以上、より好ましくは、0.3質量%以上である。これにより、良好な収斂感の抑制効果を付与できる。上限は、通常、5質量%以下、好ましくは、1質量%以下、より好ましくは0.8質量%以下である。これにより、サッパリ感の低下及び香味発現性の低下を抑制できる。従って、(C)成分の含有量は、通常、0.01~5質量%、好ましくは、0.1~1質量%、より好ましくは、0.3~1質量%、更に好ましくは0.3~0.8質量%である。
The content of the component (C) is usually 0.01% by mass or more, preferably 0.1% by mass or more, more preferably 0.3% by mass, based on the entire oral composition (100% by mass). That is all. This makes it possible to impart a good effect of suppressing a feeling of convergence. The upper limit is usually 5% by mass or less, preferably 1% by mass or less, and more preferably 0.8% by mass or less. This makes it possible to suppress a decrease in refreshing feeling and a decrease in flavor expression. Therefore, the content of the component (C) is usually 0.01 to 5% by mass, preferably 0.1 to 1% by mass, more preferably 0.3 to 1% by mass, and further preferably 0.3. It is about 0.8% by mass.
[任意成分]
本実施形態の口腔用組成物は、本発明の効果を損なわない範囲で、既に説明した(A)~(C)成分以外の任意成分を含有していてもよい。 [Arbitrary ingredient]
The oral composition of the present embodiment may contain arbitrary components other than the components (A) to (C) already described, as long as the effects of the present invention are not impaired.
本実施形態の口腔用組成物は、本発明の効果を損なわない範囲で、既に説明した(A)~(C)成分以外の任意成分を含有していてもよい。 [Arbitrary ingredient]
The oral composition of the present embodiment may contain arbitrary components other than the components (A) to (C) already described, as long as the effects of the present invention are not impaired.
任意成分としては、例えば、界面活性剤、甘味剤、香料、薬効成分、油性成分、研磨剤、防腐剤、湿潤剤、粘結剤、pH調整剤、着色剤(色素)、溶媒が挙げられる。以下、具体的に説明する。
Examples of the optional component include a surfactant, a sweetener, a fragrance, a medicinal component, an oily component, an abrasive, a preservative, a wetting agent, a binder, a pH adjuster, a colorant (dye), and a solvent. Hereinafter, a specific description will be given.
-研磨剤-
研磨剤は、無機研磨剤及び有機研磨剤のいずれでもよい。無機研磨剤としては、例えば、沈降性シリカ、アルミノシリケート、ジルコノシリケート、結晶性ジルコニウムシリケート、チタン結合性シリカ等の研磨性シリカ;第2リン酸カルシウム・2水和塩又は無水和物、第1リン酸カルシウム、第3リン酸カルシウム、ピロリン酸カルシウム等のリン酸カルシウム系化合物;炭酸カルシウム等の炭酸カルシウム系研磨剤;水酸化カルシウム、硫酸カルシウム等の、炭酸/リン酸以外のカルシウム系研磨剤;酸化アルミニウム、水酸化アルミニウム、アルミナ等のアルミニウム系材料;無水ケイ酸、ゼオライト、ケイ酸ジルコニウム等のケイ酸系材料;炭酸マグネシウム、第3リン酸マグネシウム等のマグネシウム系材料;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト系材料;二酸化チタン、雲母チタン、酸化チタン等のチタン系材料;ベントナイト等の鉱物が挙げられる。有機研磨剤としては、例えば、ポリメチルメタアクリレート、合成樹脂系研磨剤が挙げられる。これらのうち、好ましくはシリカ系研磨剤である。 -Abrasive-
The abrasive may be either an inorganic abrasive or an organic abrasive. Examples of the inorganic abrasive include abrasive silica such as precipitate silica, aluminosilicate, zirconosilicate, crystalline zirconium silicate, and titanium-binding silica; calcium dibasic phosphate / dihydrate or anhydrous, calcium primary phosphate. , Calcium phosphate-based compounds such as tertiary calcium phosphate and calcium pyrophosphate; calcium carbonate-based abrasives such as calcium carbonate; calcium-based abrasives other than carbonic acid / phosphoric acid such as calcium hydroxide and calcium sulfate; aluminum oxide, aluminum hydroxide, Aluminum-based materials such as alumina; Silica-based materials such as silicic acid anhydride, zeolite, and zirconium silicate; Magnesium-based materials such as magnesium carbonate and tertiary magnesium phosphate; Apatite-based materials such as hydroxyapatite, fluoroapatite, and calcium-deficient apatite. Materials: Titanium-based materials such as titanium dioxide, mica titanium, and titanium oxide; minerals such as bentonite can be mentioned. Examples of the organic abrasive include polymethylmethacrylate and synthetic resin-based abrasives. Of these, a silica-based abrasive is preferable.
研磨剤は、無機研磨剤及び有機研磨剤のいずれでもよい。無機研磨剤としては、例えば、沈降性シリカ、アルミノシリケート、ジルコノシリケート、結晶性ジルコニウムシリケート、チタン結合性シリカ等の研磨性シリカ;第2リン酸カルシウム・2水和塩又は無水和物、第1リン酸カルシウム、第3リン酸カルシウム、ピロリン酸カルシウム等のリン酸カルシウム系化合物;炭酸カルシウム等の炭酸カルシウム系研磨剤;水酸化カルシウム、硫酸カルシウム等の、炭酸/リン酸以外のカルシウム系研磨剤;酸化アルミニウム、水酸化アルミニウム、アルミナ等のアルミニウム系材料;無水ケイ酸、ゼオライト、ケイ酸ジルコニウム等のケイ酸系材料;炭酸マグネシウム、第3リン酸マグネシウム等のマグネシウム系材料;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト系材料;二酸化チタン、雲母チタン、酸化チタン等のチタン系材料;ベントナイト等の鉱物が挙げられる。有機研磨剤としては、例えば、ポリメチルメタアクリレート、合成樹脂系研磨剤が挙げられる。これらのうち、好ましくはシリカ系研磨剤である。 -Abrasive-
The abrasive may be either an inorganic abrasive or an organic abrasive. Examples of the inorganic abrasive include abrasive silica such as precipitate silica, aluminosilicate, zirconosilicate, crystalline zirconium silicate, and titanium-binding silica; calcium dibasic phosphate / dihydrate or anhydrous, calcium primary phosphate. , Calcium phosphate-based compounds such as tertiary calcium phosphate and calcium pyrophosphate; calcium carbonate-based abrasives such as calcium carbonate; calcium-based abrasives other than carbonic acid / phosphoric acid such as calcium hydroxide and calcium sulfate; aluminum oxide, aluminum hydroxide, Aluminum-based materials such as alumina; Silica-based materials such as silicic acid anhydride, zeolite, and zirconium silicate; Magnesium-based materials such as magnesium carbonate and tertiary magnesium phosphate; Apatite-based materials such as hydroxyapatite, fluoroapatite, and calcium-deficient apatite. Materials: Titanium-based materials such as titanium dioxide, mica titanium, and titanium oxide; minerals such as bentonite can be mentioned. Examples of the organic abrasive include polymethylmethacrylate and synthetic resin-based abrasives. Of these, a silica-based abrasive is preferable.
研磨剤の含有量は、口腔用組成物全体(100質量%)に対し、通常、70質量%以下、好ましくは50質量%以下、より好ましくは8~50質量%である。
The content of the abrasive is usually 70% by mass or less, preferably 50% by mass or less, and more preferably 8 to 50% by mass with respect to the entire oral composition (100% by mass).
-界面活性剤-
(C)成分以外の界面活性剤としては、例えば、アニオン界面活性剤、両性界面活性剤、カチオン界面活性剤が挙げられる。 -Surfactant-
Examples of the surfactant other than the component (C) include an anionic surfactant, an amphoteric surfactant, and a cationic surfactant.
(C)成分以外の界面活性剤としては、例えば、アニオン界面活性剤、両性界面活性剤、カチオン界面活性剤が挙げられる。 -Surfactant-
Examples of the surfactant other than the component (C) include an anionic surfactant, an amphoteric surfactant, and a cationic surfactant.
アニオン界面活性剤としては、例えば、アルキル硫酸塩、アシルアミノ酸塩、アシルタウリン塩、α-オレフィンスルホン酸塩、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸塩、ラウリルスルホ酢酸塩が挙げられる。アルキル基、アシル基は直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20であり、好ましくは12~18であり、より好ましくは12~14である。塩は、薬理学的に許容される塩から選択され得る。薬理学的に許容される塩としては、例えば、塩基付加塩及びアミノ酸塩が挙げられる。その具体例としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、無機塩基塩が好ましく、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩)又はアンモニウム塩がより好ましく、ナトリウム塩がさらに好ましい。
Examples of the anionic surfactant include alkyl sulfates, acyl amino acid salts, acyl taurine salts, α-olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfates, and lauryl sulfoacetates. The alkyl group and the acyl group may be either a straight chain or a branched chain, and may be saturated or unsaturated, and the number of carbon atoms thereof is usually 10 to 20, preferably 12 to 18, and more preferably 12 to 18. It is 14. The salt can be selected from pharmacologically acceptable salts. Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts. Specific examples thereof include inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt; organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt; arginine salt and the like. Basic amino acid salts of. Of these, inorganic base salts are preferred, alkali metal salts (eg, sodium salts, potassium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
アルキル硫酸塩としては、例えば、ラウリル硫酸塩(ラウリル硫酸ナトリウム)、ミリストイル硫酸塩が挙げられる。アシルアミノ酸塩としては、例えば、ラウロイルサルコシン塩、ミリストイルサルコシン塩等のアシルサルコシン塩;ラウロイルグルタミン酸塩、ミリストイルグルタミン酸塩、パルミトイルグルタミン酸塩等のアシルグルタミン酸塩;N-ラウロイル-N-メチルグリシン塩、ココイルグリシン塩等のアシルグリシン塩;N-ラウロイル-β-アラニン塩、N-ミリスチル-β-アラニン塩、N-ココイル-β-アラニン塩、N-ラウロイル-N-メチル-β-アラニン塩、N-ミリストイル-N-メチル-β-アラニン塩、N-メチル-N-アシルアラニン塩等のアシルアラニン塩;ラウロイルアスパラギン酸塩等のアシルアスパラギン酸塩が挙げられる。アシルタウリン塩としては、例えば、ラウロイルメチルタウリン塩、N-メチル-N-アシルタウリン塩、N-ココイルメチルタウリン塩が挙げられる。α-オレフィンスルホン酸塩としては、テトラデセンスルホン酸塩等の炭素原子数12~18のα-オレフィンスルホン酸塩が挙げられる。アニオン界面活性剤の他の例としては、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウムが挙げられる。
Examples of the alkyl sulfate include lauryl sulfate (sodium lauryl sulfate) and myristyl sulfate. Examples of the acyl amino acid salt include acyl sarcosine salts such as lauroyl sarcosin salt and myristoyl sarcosin salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycine salt and cocoyl glycine. Acylglycine salts such as salts; N-lauroyl-β-alanine salt, N-myristyl-β-alanine salt, N-cocoyl-β-alanine salt, N-lauroyl-N-methyl-β-alanine salt, N-myristoyl Acylalanine salts such as -N-methyl-β-alanine salt, N-methyl-N-acylalanine salt; acylasparaginate such as lauroyl asparagate can be mentioned. Examples of the acyl taurine salt include lauroylmethyl taurine salt, N-methyl-N-acyl taurine salt, and N-cocoyl methyl taurine salt. Examples of the α-olefin sulfonate include α-olefin sulfonates having 12 to 18 carbon atoms such as tetradecene sulfonate. Other examples of anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
アニオン界面活性剤は、泡立ち、泡質の良さの点で、スルホン酸基を含有することが好ましく、アルキル硫酸塩、α-オレフィンスルホン酸塩がより好ましい。
The anionic surfactant preferably contains a sulfonic acid group in terms of foaming and good foam quality, and more preferably an alkyl sulfate or an α-olefin sulfonate.
両性界面活性剤としては、例えば、アルキルジメチルアミノ酢酸ベタイン(例えば、ラウリルジメチルアミノ酢酸ベタイン)、脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(例えば、コカミドプロピルベタイン)等のベタイン型両性界面活性剤;N-脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルエチレンジアミン塩(例えば、N-ヤシ油脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン)、ヤシ油脂肪酸イミダゾリニウムベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン等のイミダゾリン型両性界面活性剤;ラウリルジメチルアミノ酢酸ベタイン等のアルキルベタインが挙げられる。カチオン界面活性剤としては、例えば、アルキルアンモニウム塩、アルキルベンジルアンモニウム塩が挙げられる。
Examples of the amphoteric surfactant include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine) and fatty acid amide propyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); N-. Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salt (eg, N-palm oil fatty acid acyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine), coconut oil fatty acid imidazolinium betaine, 2-alkyl Examples include imidazoline-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine; alkyl betaines such as lauryldimethylaminoacetic acid betaine. Examples of the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
カチオン界面活性剤としては、例えば、アルキルアンモニウム塩、アルキルベンジルアンモニウム塩が挙げられる。
Examples of the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
界面活性剤((C)成分以外)の含有量は、口腔用組成物全体(100質量%)に対し、好ましくは0.1~3質量%、より好ましくは0.6~2.5質量%、さらに好ましくは1~2.5質量%である。
The content of the surfactant (other than the component (C)) is preferably 0.1 to 3% by mass, more preferably 0.6 to 2.5% by mass, based on the entire oral composition (100% by mass). , More preferably 1 to 2.5% by mass.
-湿潤剤-
口腔用組成物が湿潤剤を含むことにより、使用感をより向上させることができる。 -Wetting agent-
When the oral composition contains a wetting agent, the feeling of use can be further improved.
口腔用組成物が湿潤剤を含むことにより、使用感をより向上させることができる。 -Wetting agent-
When the oral composition contains a wetting agent, the feeling of use can be further improved.
湿潤剤としては、糖アルコール、糖アルコール以外の多価アルコールが好ましい。糖アルコールとしては、例えば、ソルビトール、エリスリトール、マルチトール、ラクチトール、キシリトール、還元澱粉糖化物等の糖アルコール;グリセリン;エチレングリコール、プロピレングリコール、ジプロピレングリコール、ブチレングリコール、ポリエチレングリコール等の多価アルコールが挙げられる。ポリエチレングリコールとしては、例えば、平均分子量150~6000のポリエチレングリコールが挙げられ、好ましくは、平均分子量190~630のポリエチレングリコールである。具体的には、PEG200、PEG300、PEG400、PEG600が挙げられる。湿潤剤の含有量は、口腔用組成物全体(100質量%)に対し、通常、40質量%以下であり、好ましくは1~30質量%である。平均分子量は、医薬部外品原料規格2006記載の平均分子量である。
As the wetting agent, sugar alcohols and polyhydric alcohols other than sugar alcohols are preferable. Examples of the sugar alcohol include sugar alcohols such as sorbitol, erythritol, martitol, lactitol, xylitol, and reduced starch saccharified; glycerin; polyhydric alcohols such as ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, and polyethylene glycol. Can be mentioned. Examples of the polyethylene glycol include polyethylene glycol having an average molecular weight of 150 to 6000, and polyethylene glycol having an average molecular weight of 190 to 630 is preferable. Specific examples thereof include PEG200, PEG300, PEG400 and PEG600. The content of the wetting agent is usually 40% by mass or less, preferably 1 to 30% by mass, based on the entire oral composition (100% by mass). The average molecular weight is the average molecular weight described in the Quasi-drug Raw Material Standard 2006.
-薬効成分-
薬効成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、グルコン酸亜鉛、クエン酸亜鉛、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、グリチルリチン酸塩(例えば、グリチルリチン2カリウム塩)、グリチルレチン酸、グリチルレチン酸塩(例えば、グリチルレチン酸ステアリル)、アラントインクロルヒドロキシアルミニウム、アズレン、ジヒドロコレステロール等の抗炎症剤;亜鉛、銅塩、スズ塩等の金属塩;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;硝酸カリウム、乳酸アルミニウム、塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸またはその塩)、塩化リゾチーム等の(A)成分以外の収斂剤;銅クロロフィル、グルコン酸銅等の水溶性銅化合物;歯石予防剤、アラニン、グリシン、プロリン等のアミノ酸類、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。薬効成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬効成分の含有量は、常法に従って有効量を適宜設定できる。 -Medicinal ingredient-
Examples of the medicinal ingredient include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timol, hinokithiol, and lysoteam chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ε-aminocaproic acid, allantin, tranexamic acid, glycyrrhizinate (eg, glycyrrhetin dipotassium salt) ), Anti-inflammatory agents such as glycyrrhetinic acid, glycyrrhetinate (eg, stearyl glycyrrhetinate), allantinchlorhydroxyaluminum, azulene, dihydrocholesterol; metal salts such as zinc, copper salt, tin salt; condensed phosphate, ethanehydroxy Toothstone preventive agent such as diphosphonate; Blood flow promoter such as vitamin E (for example, tocopherol acetate); Sensitivity inhibitor such as potassium nitrate, aluminum lactate, strontium chloride; Coating agent such as hydroxyethyl cellulose dimethyldiallyl ammonium chloride; Astringents other than component (A) such as vitamin C (eg, ascorbic acid or a salt thereof), lysoteam chloride; water-soluble copper compounds such as copper chlorophyll and copper gluconate; amino acids such as tooth stone preventives, alanine, glycine and proline. Kinds, thyme, ginger, chowji, hamamelis and other plant extracts; caropeptides, polyvinylpyrrolidone and the like. The medicinal ingredient may be used alone or in combination of two or more. The content of the medicinal ingredient can be appropriately set as an effective amount according to a conventional method.
薬効成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、グルコン酸亜鉛、クエン酸亜鉛、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、グリチルリチン酸塩(例えば、グリチルリチン2カリウム塩)、グリチルレチン酸、グリチルレチン酸塩(例えば、グリチルレチン酸ステアリル)、アラントインクロルヒドロキシアルミニウム、アズレン、ジヒドロコレステロール等の抗炎症剤;亜鉛、銅塩、スズ塩等の金属塩;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;硝酸カリウム、乳酸アルミニウム、塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸またはその塩)、塩化リゾチーム等の(A)成分以外の収斂剤;銅クロロフィル、グルコン酸銅等の水溶性銅化合物;歯石予防剤、アラニン、グリシン、プロリン等のアミノ酸類、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。薬効成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬効成分の含有量は、常法に従って有効量を適宜設定できる。 -Medicinal ingredient-
Examples of the medicinal ingredient include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timol, hinokithiol, and lysoteam chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ε-aminocaproic acid, allantin, tranexamic acid, glycyrrhizinate (eg, glycyrrhetin dipotassium salt) ), Anti-inflammatory agents such as glycyrrhetinic acid, glycyrrhetinate (eg, stearyl glycyrrhetinate), allantinchlorhydroxyaluminum, azulene, dihydrocholesterol; metal salts such as zinc, copper salt, tin salt; condensed phosphate, ethanehydroxy Toothstone preventive agent such as diphosphonate; Blood flow promoter such as vitamin E (for example, tocopherol acetate); Sensitivity inhibitor such as potassium nitrate, aluminum lactate, strontium chloride; Coating agent such as hydroxyethyl cellulose dimethyldiallyl ammonium chloride; Astringents other than component (A) such as vitamin C (eg, ascorbic acid or a salt thereof), lysoteam chloride; water-soluble copper compounds such as copper chlorophyll and copper gluconate; amino acids such as tooth stone preventives, alanine, glycine and proline. Kinds, thyme, ginger, chowji, hamamelis and other plant extracts; caropeptides, polyvinylpyrrolidone and the like. The medicinal ingredient may be used alone or in combination of two or more. The content of the medicinal ingredient can be appropriately set as an effective amount according to a conventional method.
-香料-
口腔用組成物が香料を含むことにより、使用感をより向上させることができる。香料としては、例えば、ペパーミント油、スペアミント油、和種ハッカ油、アニス油、カシア油、ユーカリ油、ウィンターグリーン油、マスチック油、ネロリ油(オレンジフラワー油)、レモングラス油、ジャスミン油、ローズ油、イリス油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、バジル油、マジョラム油、レモン油、オレンジ油、ライム油、柚子油、ナツメグ油、ラベンダー油、パラクレス油、バニラ油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油等の天然精油;メントール、カルボン、シンナミックアルデヒド、アネトール、1,8-シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、デカナール、カンファー、ボルネオール、ピネン、スピラントール、n-デシルアルコール、シトロネロール、α-テルピネオール、シトロネリルアセテート、シネオール、エチルリナロール、ワニリン等の上記天然精油中に含まれる香料成分;エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンズアルデヒド、バニリン、エチルバニリン、フラネオール等の香料成分;及びいくつかの香料成分や天然精油を組み合わせてなるミント系、フルーツ系、ハーブ系等の各種調合フレーバーが挙げられる。香料としては、上記例示の香料を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Fragrance-
When the oral composition contains a fragrance, the feeling of use can be further improved. Examples of fragrances include peppermint oil, sparemint oil, Japanese peppermint oil, anis oil, cassia oil, eucalyptus oil, winter green oil, mastic oil, neroli oil (orange flower oil), lemongrass oil, jasmine oil, and rose oil. , Iris oil, clove oil, thyme oil, sage oil, cardamon oil, rosemary oil, laurel oil, chamomil oil, caraway oil, basil oil, majorum oil, lemon oil, orange oil, lime oil, yuzu oil, nutmeg oil , Lavender oil, Paracres oil, Vanilla oil, Katsura skin oil, Pimento oil, Katsura leaf oil, Perilla oil, Winter green oil and other natural essential oils; , Timor, linalol, limonen, menton, mentylacetate, citral, decanal, camphor, borneol, pinen, spirantol, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineole, ethyllinalol, varnish and other natural essential oils. Fragrance components contained in; fragrance components such as ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methyl phenylglycidate, benzaldehyde, vanillin, ethyl vaniline, flaneol; and some fragrances. Examples include various blended flavors such as mint-based, fruit-based, and herbal-based, which are a combination of ingredients and natural essential oils. As the fragrance, the above-exemplified fragrance may be used alone or in combination of two or more.
口腔用組成物が香料を含むことにより、使用感をより向上させることができる。香料としては、例えば、ペパーミント油、スペアミント油、和種ハッカ油、アニス油、カシア油、ユーカリ油、ウィンターグリーン油、マスチック油、ネロリ油(オレンジフラワー油)、レモングラス油、ジャスミン油、ローズ油、イリス油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、バジル油、マジョラム油、レモン油、オレンジ油、ライム油、柚子油、ナツメグ油、ラベンダー油、パラクレス油、バニラ油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油等の天然精油;メントール、カルボン、シンナミックアルデヒド、アネトール、1,8-シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、デカナール、カンファー、ボルネオール、ピネン、スピラントール、n-デシルアルコール、シトロネロール、α-テルピネオール、シトロネリルアセテート、シネオール、エチルリナロール、ワニリン等の上記天然精油中に含まれる香料成分;エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンズアルデヒド、バニリン、エチルバニリン、フラネオール等の香料成分;及びいくつかの香料成分や天然精油を組み合わせてなるミント系、フルーツ系、ハーブ系等の各種調合フレーバーが挙げられる。香料としては、上記例示の香料を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Fragrance-
When the oral composition contains a fragrance, the feeling of use can be further improved. Examples of fragrances include peppermint oil, sparemint oil, Japanese peppermint oil, anis oil, cassia oil, eucalyptus oil, winter green oil, mastic oil, neroli oil (orange flower oil), lemongrass oil, jasmine oil, and rose oil. , Iris oil, clove oil, thyme oil, sage oil, cardamon oil, rosemary oil, laurel oil, chamomil oil, caraway oil, basil oil, majorum oil, lemon oil, orange oil, lime oil, yuzu oil, nutmeg oil , Lavender oil, Paracres oil, Vanilla oil, Katsura skin oil, Pimento oil, Katsura leaf oil, Perilla oil, Winter green oil and other natural essential oils; , Timor, linalol, limonen, menton, mentylacetate, citral, decanal, camphor, borneol, pinen, spirantol, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineole, ethyllinalol, varnish and other natural essential oils. Fragrance components contained in; fragrance components such as ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methyl phenylglycidate, benzaldehyde, vanillin, ethyl vaniline, flaneol; and some fragrances. Examples include various blended flavors such as mint-based, fruit-based, and herbal-based, which are a combination of ingredients and natural essential oils. As the fragrance, the above-exemplified fragrance may be used alone or in combination of two or more.
-甘味剤-
口腔用組成物が甘味剤を含むことにより、使用感をより向上させることができる。甘味剤としては、例えば、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、グリチルリチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル等が挙げられる。甘味剤としては、上記例示の甘味剤を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Sweetener-
When the oral composition contains a sweetening agent, the feeling of use can be further improved. Examples of the sweetener include saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, aspartylphenylalanine methyl ester and the like. As the sweetener, the above-exemplified sweetener may be used alone or in combination of two or more.
口腔用組成物が甘味剤を含むことにより、使用感をより向上させることができる。甘味剤としては、例えば、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、グリチルリチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル等が挙げられる。甘味剤としては、上記例示の甘味剤を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Sweetener-
When the oral composition contains a sweetening agent, the feeling of use can be further improved. Examples of the sweetener include saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, aspartylphenylalanine methyl ester and the like. As the sweetener, the above-exemplified sweetener may be used alone or in combination of two or more.
-油性成分-
油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ヒマシ油、ヤシ油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。 -Oil component-
Examples of the oily component include hydrocarbons such as squalane, liquid paraffin, vaseline, and microcrystalin wax; and having 8 carbon atoms such as higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, and isostearyl alcohol). ~ 22 alcohols); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), vegetable oils such as olive oil, castor oil, palm oil; Examples include fatty acid esters.
油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ヒマシ油、ヤシ油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。 -Oil component-
Examples of the oily component include hydrocarbons such as squalane, liquid paraffin, vaseline, and microcrystalin wax; and having 8 carbon atoms such as higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, and isostearyl alcohol). ~ 22 alcohols); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), vegetable oils such as olive oil, castor oil, palm oil; Examples include fatty acid esters.
-防腐剤-
口腔用組成物が防腐剤を含むことにより、製剤(口腔用組成物)の防腐力を確保できる。防腐剤としては、例えば、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Preservative-
When the oral composition contains an antiseptic, the antiseptic power of the preparation (oral composition) can be ensured. Examples of the preservative include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like. The preservative may be used alone or in combination of two or more.
口腔用組成物が防腐剤を含むことにより、製剤(口腔用組成物)の防腐力を確保できる。防腐剤としては、例えば、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Preservative-
When the oral composition contains an antiseptic, the antiseptic power of the preparation (oral composition) can be ensured. Examples of the preservative include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like. The preservative may be used alone or in combination of two or more.
-粘結剤-
口腔用組成物が任意の粘結剤を含むことにより、粘度を最適化でき、保形性、使用感をより向上させることができる。粘結剤としては、従来公知の任意好適な有機粘結剤、例えば、多糖類、セルロース系粘結剤(例えば、カルボキシメチルセルロース(CMC)、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、その他の多糖系増粘剤(例、キサンタンガム、グアガム、ジェランガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、カラギーナン、アルギン酸ナトリウム)、合成水溶性高分子(例、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルピロリドン、ポリビニルアルコール、アルギン酸プロピレングリコール)が挙げられる。さらには増粘性シリカ、ケイ酸アルミニウム等の無機粘結剤を配合することもできる。任意の有機粘結剤の含有量は、口腔用組成物全体(100質量%)に対し、0~3質量%であることが好ましく、0.1~2質量%であることがより好ましい。無機粘結剤の含有量は、0~10質量%であることが好ましく、1~8質量%であることがより好ましい。 -Blotting agent-
When the oral composition contains an arbitrary binder, the viscosity can be optimized, and the shape retention and usability can be further improved. As the binder, any suitable organic binder conventionally known, for example, a polysaccharide, a cellulosic binder (for example, carboxymethyl cellulose (CMC), hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, cation) Celluloseized cellulose, etc.), other polysaccharide thickeners (eg, xanthan gum, gua gum, gellan gum, tragant gum, karaya gum, arabiya gum, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (eg, sodium polyacrylate, etc.) Cardovinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, propylene glycol alginate) can be mentioned. Further, an inorganic binder such as thickening silica and aluminum silicate can be blended. The content of any organic binder is preferably 0 to 3% by mass, more preferably 0.1 to 2% by mass, based on the entire oral composition (100% by mass). The content of the inorganic binder is preferably 0 to 10% by mass, more preferably 1 to 8% by mass.
口腔用組成物が任意の粘結剤を含むことにより、粘度を最適化でき、保形性、使用感をより向上させることができる。粘結剤としては、従来公知の任意好適な有機粘結剤、例えば、多糖類、セルロース系粘結剤(例えば、カルボキシメチルセルロース(CMC)、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、その他の多糖系増粘剤(例、キサンタンガム、グアガム、ジェランガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、カラギーナン、アルギン酸ナトリウム)、合成水溶性高分子(例、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルピロリドン、ポリビニルアルコール、アルギン酸プロピレングリコール)が挙げられる。さらには増粘性シリカ、ケイ酸アルミニウム等の無機粘結剤を配合することもできる。任意の有機粘結剤の含有量は、口腔用組成物全体(100質量%)に対し、0~3質量%であることが好ましく、0.1~2質量%であることがより好ましい。無機粘結剤の含有量は、0~10質量%であることが好ましく、1~8質量%であることがより好ましい。 -Blotting agent-
When the oral composition contains an arbitrary binder, the viscosity can be optimized, and the shape retention and usability can be further improved. As the binder, any suitable organic binder conventionally known, for example, a polysaccharide, a cellulosic binder (for example, carboxymethyl cellulose (CMC), hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, cation) Celluloseized cellulose, etc.), other polysaccharide thickeners (eg, xanthan gum, gua gum, gellan gum, tragant gum, karaya gum, arabiya gum, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (eg, sodium polyacrylate, etc.) Cardovinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, propylene glycol alginate) can be mentioned. Further, an inorganic binder such as thickening silica and aluminum silicate can be blended. The content of any organic binder is preferably 0 to 3% by mass, more preferably 0.1 to 2% by mass, based on the entire oral composition (100% by mass). The content of the inorganic binder is preferably 0 to 10% by mass, more preferably 1 to 8% by mass.
-pH調整剤-
口腔用組成物がpH調整剤を含むことにより、製剤(口腔用組成物)のpH安定性を確保できる。pH調整剤としては、例えば、フタル酸、クエン酸、コハク酸、酢酸、フマル酸、リンゴ酸、及び乳酸等の有機酸又はそれらの塩(クエン酸ナトリウム)、リン酸(オルトリン酸)等の無機酸又はそれらの塩(例えば、カリウム塩、ナトリウム塩及びアンモニウム塩)、水酸化ナトリウム、水酸化カリウム等の水酸化物が挙げられる。無機酸塩としては、例えば、リン酸水素二ナトリウム、リン酸二水素ナトリウムが挙げられる。 -PH regulator-
When the oral composition contains a pH adjuster, the pH stability of the pharmaceutical product (oral composition) can be ensured. Examples of the pH adjuster include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid and lactic acid, or salts thereof (sodium citrate) and inorganic acids such as phosphoric acid (orthoric acid). Acids or hydroxides thereof such as salts thereof (eg, potassium salt, sodium salt and ammonium salt), sodium hydroxide, potassium hydroxide and the like can be mentioned. Examples of the inorganic acid salt include disodium hydrogen phosphate and sodium dihydrogen phosphate.
口腔用組成物がpH調整剤を含むことにより、製剤(口腔用組成物)のpH安定性を確保できる。pH調整剤としては、例えば、フタル酸、クエン酸、コハク酸、酢酸、フマル酸、リンゴ酸、及び乳酸等の有機酸又はそれらの塩(クエン酸ナトリウム)、リン酸(オルトリン酸)等の無機酸又はそれらの塩(例えば、カリウム塩、ナトリウム塩及びアンモニウム塩)、水酸化ナトリウム、水酸化カリウム等の水酸化物が挙げられる。無機酸塩としては、例えば、リン酸水素二ナトリウム、リン酸二水素ナトリウムが挙げられる。 -PH regulator-
When the oral composition contains a pH adjuster, the pH stability of the pharmaceutical product (oral composition) can be ensured. Examples of the pH adjuster include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid and lactic acid, or salts thereof (sodium citrate) and inorganic acids such as phosphoric acid (orthoric acid). Acids or hydroxides thereof such as salts thereof (eg, potassium salt, sodium salt and ammonium salt), sodium hydroxide, potassium hydroxide and the like can be mentioned. Examples of the inorganic acid salt include disodium hydrogen phosphate and sodium dihydrogen phosphate.
pH調整剤の含有量は、通常、添加後の口腔用組成物のpHが5~9、好ましくは6~8.5となる量とすることができる。
The content of the pH adjuster can usually be such that the pH of the oral composition after addition is 5 to 9, preferably 6 to 8.5.
本明細書において、pH値は、通常、測定開始から25℃、3分後の値をいう。pH値は、例えば、東亜電波工業社製のpHメーター(型番Hm-30S)を用いて測定することができる。
In the present specification, the pH value usually means a value at 25 ° C. and 3 minutes after the start of measurement. The pH value can be measured using, for example, a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
-着色剤-
着色剤としては例えば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、タマリンド色素等の天然色素や、赤色2号、赤色3号、赤色104号、赤色105号、赤色106号、赤色227号、黄色4号、黄色5号、緑色3号、青色1号等の法定色素、リボフラビン、銅クロロフィンナトリウム、二酸化チタン等が挙げられる。口腔用組成物が着色剤を含む場合、その含有量は、口腔用組成物の全体に対し0.00001~3質量%とすることが好ましい。 -Colorant-
Examples of the colorant include natural pigments such as Benibana red pigment, Kuchinashi yellow element, Kuchinashi blue pigment, perilla pigment, red koji pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, and tamarind pigment. Legal dyes such as Red No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, Blue No. 1, Riboflavin, Copper Chlorophine Sodium , Titanium dioxide and the like. When the oral composition contains a colorant, the content thereof is preferably 0.00001 to 3% by mass with respect to the entire oral composition.
着色剤としては例えば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、タマリンド色素等の天然色素や、赤色2号、赤色3号、赤色104号、赤色105号、赤色106号、赤色227号、黄色4号、黄色5号、緑色3号、青色1号等の法定色素、リボフラビン、銅クロロフィンナトリウム、二酸化チタン等が挙げられる。口腔用組成物が着色剤を含む場合、その含有量は、口腔用組成物の全体に対し0.00001~3質量%とすることが好ましい。 -Colorant-
Examples of the colorant include natural pigments such as Benibana red pigment, Kuchinashi yellow element, Kuchinashi blue pigment, perilla pigment, red koji pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, and tamarind pigment. Legal dyes such as Red No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, Blue No. 1, Riboflavin, Copper Chlorophine Sodium , Titanium dioxide and the like. When the oral composition contains a colorant, the content thereof is preferably 0.00001 to 3% by mass with respect to the entire oral composition.
-溶媒-
溶媒としては、例えば、水(精製水)、エタノール等が挙げられ、水が好ましい。溶媒は1種を単独で用いても2種以上を組み合わせて用いてもよい。 -solvent-
Examples of the solvent include water (purified water), ethanol and the like, and water is preferable. As the solvent, one type may be used alone or two or more types may be used in combination.
溶媒としては、例えば、水(精製水)、エタノール等が挙げられ、水が好ましい。溶媒は1種を単独で用いても2種以上を組み合わせて用いてもよい。 -solvent-
Examples of the solvent include water (purified water), ethanol and the like, and water is preferable. As the solvent, one type may be used alone or two or more types may be used in combination.
-他の任意成分-
上記以外の任意成分の例としては、ポリイソブチレン、ポリブタジエン、ウレタン、シリコン、天然ゴムが挙げられる。これら他の任意成分の含有量は、本発明の効果を妨げない範囲で適宜設定できる。 -Other optional ingredients-
Examples of optional components other than the above include polyisobutylene, polybutadiene, urethane, silicon, and natural rubber. The content of these other optional components can be appropriately set as long as the effect of the present invention is not impaired.
上記以外の任意成分の例としては、ポリイソブチレン、ポリブタジエン、ウレタン、シリコン、天然ゴムが挙げられる。これら他の任意成分の含有量は、本発明の効果を妨げない範囲で適宜設定できる。 -Other optional ingredients-
Examples of optional components other than the above include polyisobutylene, polybutadiene, urethane, silicon, and natural rubber. The content of these other optional components can be appropriately set as long as the effect of the present invention is not impaired.
[口腔用組成物の剤形及び用途]
本発明の口腔用組成物は、歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤等の口腔用製剤とすることができる。
口腔用組成物の剤形は、利用形態に応じて適宜選択することができ、特に限定されない。剤形としては、例えば、ペースト状、液状等の形態で、歯磨剤であれば練歯磨、液体歯磨、液状歯磨、潤製歯磨として調製できる。 [Dosage form and use of oral composition]
The oral composition of the present invention can be an oral preparation such as a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
The dosage form of the oral composition can be appropriately selected depending on the usage form, and is not particularly limited. The dosage form is, for example, in the form of a paste or liquid, and if it is a dentifrice, it can be prepared as a dentifrice, a liquid dentifrice, a liquid dentifrice, or a dentifrice.
本発明の口腔用組成物は、歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤等の口腔用製剤とすることができる。
口腔用組成物の剤形は、利用形態に応じて適宜選択することができ、特に限定されない。剤形としては、例えば、ペースト状、液状等の形態で、歯磨剤であれば練歯磨、液体歯磨、液状歯磨、潤製歯磨として調製できる。 [Dosage form and use of oral composition]
The oral composition of the present invention can be an oral preparation such as a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
The dosage form of the oral composition can be appropriately selected depending on the usage form, and is not particularly limited. The dosage form is, for example, in the form of a paste or liquid, and if it is a dentifrice, it can be prepared as a dentifrice, a liquid dentifrice, a liquid dentifrice, or a dentifrice.
[口腔用組成物の製造方法]
口腔用組成物の製造方法は特に限定されず、剤形に応じて、それぞれの通常の方法で調製され得る。例えば練歯磨剤として利用する場合、溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて脱泡(例えば、減圧等)を行う方法が挙げられる。得られる練歯磨は、容器に収容して製品とすることができる。容器は、形状、材質は特に制限されず、通常の歯磨剤組成物に使用される容器を使用でき、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック製のラミネートチューブ等の容器等が挙げられる。 [Manufacturing method of oral composition]
The method for producing the oral composition is not particularly limited, and can be prepared by each usual method depending on the dosage form. For example, when it is used as a dentifrice, a method of preparing a component that dissolves in a solvent, mixing other insoluble components, and defoaming (for example, reducing the pressure) as necessary can be mentioned. The obtained toothpaste can be contained in a container and made into a product. The shape and material of the container are not particularly limited, and a container used for a normal dentifrice composition can be used. For example, a container such as a plastic laminated tube such as polyethylene, polypropylene, polyethylene terephthalate, or nylon can be used. Be done.
口腔用組成物の製造方法は特に限定されず、剤形に応じて、それぞれの通常の方法で調製され得る。例えば練歯磨剤として利用する場合、溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて脱泡(例えば、減圧等)を行う方法が挙げられる。得られる練歯磨は、容器に収容して製品とすることができる。容器は、形状、材質は特に制限されず、通常の歯磨剤組成物に使用される容器を使用でき、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック製のラミネートチューブ等の容器等が挙げられる。 [Manufacturing method of oral composition]
The method for producing the oral composition is not particularly limited, and can be prepared by each usual method depending on the dosage form. For example, when it is used as a dentifrice, a method of preparing a component that dissolves in a solvent, mixing other insoluble components, and defoaming (for example, reducing the pressure) as necessary can be mentioned. The obtained toothpaste can be contained in a container and made into a product. The shape and material of the container are not particularly limited, and a container used for a normal dentifrice composition can be used. For example, a container such as a plastic laminated tube such as polyethylene, polypropylene, polyethylene terephthalate, or nylon can be used. Be done.
以下、実施例及び比較例を示して本発明を具体的に説明する。本発明は下記実施例に制限されない。なお、下記表中の数値は特に断らない限り質量%を表す。
Hereinafter, the present invention will be specifically described with reference to Examples and Comparative Examples. The present invention is not limited to the following examples. The values in the table below represent mass% unless otherwise specified.
[実施例及び比較例において使用された成分]
-(A)成分-
炭酸水素ナトリウム:重炭酸ナトリウム(旭硝子(株)製)
硫酸ナトリウム:無水硫酸ナトリウム(富田製薬(株)製)
塩化ナトリウム:(精選特級塩、日本海水(株)製)
硫酸アルミニウムカリウム:(大明化学工業(株)製) [Ingredients used in Examples and Comparative Examples]
-(A) component-
Sodium hydrogen carbonate: Sodium bicarbonate (manufactured by Asahi Glass Co., Ltd.)
Sodium sulfate: Anhydrous sodium sulfate (manufactured by Tomita Pharmaceutical Co., Ltd.)
Sodium chloride: (Selected special grade salt, manufactured by Nihonkaisui Co., Ltd.)
Potassium aluminum sulfate: (manufactured by Taimei Chemicals Co., Ltd.)
-(A)成分-
炭酸水素ナトリウム:重炭酸ナトリウム(旭硝子(株)製)
硫酸ナトリウム:無水硫酸ナトリウム(富田製薬(株)製)
塩化ナトリウム:(精選特級塩、日本海水(株)製)
硫酸アルミニウムカリウム:(大明化学工業(株)製) [Ingredients used in Examples and Comparative Examples]
-(A) component-
Sodium hydrogen carbonate: Sodium bicarbonate (manufactured by Asahi Glass Co., Ltd.)
Sodium sulfate: Anhydrous sodium sulfate (manufactured by Tomita Pharmaceutical Co., Ltd.)
Sodium chloride: (Selected special grade salt, manufactured by Nihonkaisui Co., Ltd.)
Potassium aluminum sulfate: (manufactured by Taimei Chemicals Co., Ltd.)
-(B)成分-
N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド:(Coolact(登録商標)370、高砂香料工業(株)社製)
エチル-3-(p-メンタン-3-カルボキサミド)アセテート:(WS-5、豊玉香料(株)製)
N-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミド:(Evercool(登録商標)190、ジボダン社製)
N-エチル-p-メンタン-3-カルボキサミド:(WS-3、シムライズジャパン社製) -(B) component-
N- (2-Hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide: (Coolact® 370, manufactured by Takasago International Corporation)
Ethyl-3- (p-menthane-3-carboxamide) acetate: (WS-5, manufactured by Toyoda Fragrance Co., Ltd.)
N- (2- (2-pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide: (Evercool® 190, manufactured by Givaudan)
N-Ethyl-p-Menthane-3-carboxamide: (WS-3, manufactured by Simrise Japan)
N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド:(Coolact(登録商標)370、高砂香料工業(株)社製)
エチル-3-(p-メンタン-3-カルボキサミド)アセテート:(WS-5、豊玉香料(株)製)
N-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミド:(Evercool(登録商標)190、ジボダン社製)
N-エチル-p-メンタン-3-カルボキサミド:(WS-3、シムライズジャパン社製) -(B) component-
N- (2-Hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide: (Coolact® 370, manufactured by Takasago International Corporation)
Ethyl-3- (p-menthane-3-carboxamide) acetate: (WS-5, manufactured by Toyoda Fragrance Co., Ltd.)
N- (2- (2-pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide: (Evercool® 190, manufactured by Givaudan)
N-Ethyl-p-Menthane-3-carboxamide: (WS-3, manufactured by Simrise Japan)
-(C)成分-
ポリオキシエチレン(20)硬化ヒマシ油:(日本エマルジョン(株)製) -(C) component-
Polyoxyethylene (20) Hardened castor oil: (manufactured by Nippon Emulsion Co., Ltd.)
ポリオキシエチレン(20)硬化ヒマシ油:(日本エマルジョン(株)製) -(C) component-
Polyoxyethylene (20) Hardened castor oil: (manufactured by Nippon Emulsion Co., Ltd.)
(A)~(C)成分以外の成分
研磨性シリカ:Tixosil(登録商標)73(Solvay社製)
フッ化ナトリウム:(ステラケミファ(株)製)
ラウリル硫酸ナトリウム:(BASF社製)
ソルビット液(70%):(三菱商事ライフサイエンス(株)製)
プロピレングリコール:(ADEKA社製)
増粘性シリカ:カープレックス(登録商標)#67(DSLジャパン(株)製)
サッカリンナトリウム:(愛三化学工業(株)製)
水(精製水)
上記以外の成分については医薬部外品原料規格2006に適合した原料を用いた。 Ingredients other than the components (A) to (C) Abrasive silica: Tixosil (registered trademark) 73 (manufactured by Solvay)
Sodium fluoride: (manufactured by Stella Chemipha Co., Ltd.)
Sodium lauryl sulfate: (manufactured by BASF)
Sorbitol liquid (70%): (manufactured by Mitsubishi Corporation Life Science Co., Ltd.)
Propylene glycol: (manufactured by ADEKA)
Viscous silica: Carplex (registered trademark) # 67 (manufactured by DSL Japan Co., Ltd.)
Saccharin sodium: (manufactured by Aisan Chemical Industry Co., Ltd.)
Water (purified water)
For ingredients other than the above, raw materials conforming to the quasi-drug raw material standard 2006 were used.
研磨性シリカ:Tixosil(登録商標)73(Solvay社製)
フッ化ナトリウム:(ステラケミファ(株)製)
ラウリル硫酸ナトリウム:(BASF社製)
ソルビット液(70%):(三菱商事ライフサイエンス(株)製)
プロピレングリコール:(ADEKA社製)
増粘性シリカ:カープレックス(登録商標)#67(DSLジャパン(株)製)
サッカリンナトリウム:(愛三化学工業(株)製)
水(精製水)
上記以外の成分については医薬部外品原料規格2006に適合した原料を用いた。 Ingredients other than the components (A) to (C) Abrasive silica: Tixosil (registered trademark) 73 (manufactured by Solvay)
Sodium fluoride: (manufactured by Stella Chemipha Co., Ltd.)
Sodium lauryl sulfate: (manufactured by BASF)
Sorbitol liquid (70%): (manufactured by Mitsubishi Corporation Life Science Co., Ltd.)
Propylene glycol: (manufactured by ADEKA)
Viscous silica: Carplex (registered trademark) # 67 (manufactured by DSL Japan Co., Ltd.)
Saccharin sodium: (manufactured by Aisan Chemical Industry Co., Ltd.)
Water (purified water)
For ingredients other than the above, raw materials conforming to the quasi-drug raw material standard 2006 were used.
実施例1~28及び比較例1~8
上記成分を原料として用いて、後述する調製方法に従って、下記表1~5に示す配合組成を有する練歯磨剤を調製した。 Examples 1-28 and Comparative Examples 1-8
Using the above components as raw materials, dentifrices having the composition shown in Tables 1 to 5 below were prepared according to the preparation method described later.
上記成分を原料として用いて、後述する調製方法に従って、下記表1~5に示す配合組成を有する練歯磨剤を調製した。 Examples 1-28 and Comparative Examples 1-8
Using the above components as raw materials, dentifrices having the composition shown in Tables 1 to 5 below were prepared according to the preparation method described later.
[練歯磨剤の調製方法]
表1~5に示される原料を常法により配合して練歯磨剤を得て、これをラミネートチューブに収容した。 [Preparation method of dentifrice]
The raw materials shown in Tables 1 to 5 were blended by a conventional method to obtain a dentifrice, which was housed in a laminated tube.
表1~5に示される原料を常法により配合して練歯磨剤を得て、これをラミネートチューブに収容した。 [Preparation method of dentifrice]
The raw materials shown in Tables 1 to 5 were blended by a conventional method to obtain a dentifrice, which was housed in a laminated tube.
[評価方法]
被験者パネラー4名によって練歯磨剤の使用感を評価した。歯ブラシ(クリニカアドバンテージハブラシ、4列コンパクトふつうタイプ、ライオン(株)製)にサンプルの練歯磨剤1gを載せ、3分間歯みがきを行い、サッパリ感、収斂感の抑制効果、収斂感の抑制効果の持続性について、それぞれ下記に示す評点基準によって判定した。4名の点数の平均を求め、下記の評価基準によって評価した。 [Evaluation method]
The feeling of use of the dentifrice was evaluated by four subject panelists. Place 1g of sample dentifrice on a toothbrush (Clinica Advantage Toothbrush, 4-row compact normal type, manufactured by Lion Corporation), brush the teeth for 3 minutes, and maintain the refreshing feeling, the effect of suppressing the feeling of convergence, and the effect of suppressing the feeling of convergence. The sex was judged according to the score criteria shown below. The average of the scores of the four people was calculated and evaluated according to the following evaluation criteria.
被験者パネラー4名によって練歯磨剤の使用感を評価した。歯ブラシ(クリニカアドバンテージハブラシ、4列コンパクトふつうタイプ、ライオン(株)製)にサンプルの練歯磨剤1gを載せ、3分間歯みがきを行い、サッパリ感、収斂感の抑制効果、収斂感の抑制効果の持続性について、それぞれ下記に示す評点基準によって判定した。4名の点数の平均を求め、下記の評価基準によって評価した。 [Evaluation method]
The feeling of use of the dentifrice was evaluated by four subject panelists. Place 1g of sample dentifrice on a toothbrush (Clinica Advantage Toothbrush, 4-row compact normal type, manufactured by Lion Corporation), brush the teeth for 3 minutes, and maintain the refreshing feeling, the effect of suppressing the feeling of convergence, and the effect of suppressing the feeling of convergence. The sex was judged according to the score criteria shown below. The average of the scores of the four people was calculated and evaluated according to the following evaluation criteria.
<サッパリ感>
サッパリ感に関しては、歯みがき後に水で口腔内をすすいだ後の口腔内のネバツキの有無によるサッパリ感に関して評価を行った。
評点基準
4点:非常にサッパリ感を感じた
3点:サッパリ感を感じた
2点:あまりサッパリ感を感じなかった
1点:サッパリ感を感じなかった
評価基準
優:平均点3.5点以上4.0点以下
良:平均点3.0点以上3.5点未満
可:平均点2.0点以上3.0点未満
不可:平均点2.0点未満 <Refreshing feeling>
Regarding the refreshing feeling, the refreshing feeling was evaluated depending on the presence or absence of stickiness in the oral cavity after rinsing the oral cavity with water after brushing the teeth.
Rating criteria 4 points: Very refreshing feeling 3 points: Feeling refreshing feeling 2 points: Not feeling refreshing feeling 1 point: Feeling refreshing feeling Evaluation criteria Excellent: Average score 3.5 points or more 4.0 points or less Good: Average score 3.0 points or more and less than 3.5 points Possible: Average score 2.0 points or more and less than 3.0 points Impossible: Average score less than 2.0 points
サッパリ感に関しては、歯みがき後に水で口腔内をすすいだ後の口腔内のネバツキの有無によるサッパリ感に関して評価を行った。
評点基準
4点:非常にサッパリ感を感じた
3点:サッパリ感を感じた
2点:あまりサッパリ感を感じなかった
1点:サッパリ感を感じなかった
評価基準
優:平均点3.5点以上4.0点以下
良:平均点3.0点以上3.5点未満
可:平均点2.0点以上3.0点未満
不可:平均点2.0点未満 <Refreshing feeling>
Regarding the refreshing feeling, the refreshing feeling was evaluated depending on the presence or absence of stickiness in the oral cavity after rinsing the oral cavity with water after brushing the teeth.
Rating criteria 4 points: Very refreshing feeling 3 points: Feeling refreshing feeling 2 points: Not feeling refreshing feeling 1 point: Feeling refreshing feeling Evaluation criteria Excellent: Average score 3.5 points or more 4.0 points or less Good: Average score 3.0 points or more and less than 3.5 points Possible: Average score 2.0 points or more and less than 3.0 points Impossible: Average score less than 2.0 points
<収斂感の抑制効果>
収斂感の抑制効果に関しては、歯みがき後に水で口腔内をすすいだ直後の収斂感の強さに関して評価を行った。
評価基準
4点:収斂感を感じなかった
3点:収斂感をほとんど感じなかった
2点:収斂感を感じた
1点:収斂感を非常に強く感じた
判定基準
秀:平均点3.8点以上4.0点以下
優:平均点3.5点以上3.8点未満
良:平均点3.0点以上3.5点未満
可:平均点2.0点以上3.0点未満
不可:平均点2.0点未満 <Suppressing effect of convergence>
Regarding the effect of suppressing the feeling of convergence, the strength of the feeling of convergence immediately after rinsing the oral cavity with water after brushing the teeth was evaluated.
Evaluation criteria 4 points: No sense of convergence 3 points: Almost no sense of convergence 2 points: Feeling of convergence 1 point: Feeling of convergence very strongly Judgment criteria Hide: Average score 3.8 points 4.0 points or less Excellent: Average score 3.5 points or more and less than 3.8 points Good: Average score 3.0 points or more and less than 3.5 points Possible: Average score 2.0 points or more and less than 3.0 points Impossible: Average score less than 2.0 points
収斂感の抑制効果に関しては、歯みがき後に水で口腔内をすすいだ直後の収斂感の強さに関して評価を行った。
評価基準
4点:収斂感を感じなかった
3点:収斂感をほとんど感じなかった
2点:収斂感を感じた
1点:収斂感を非常に強く感じた
判定基準
秀:平均点3.8点以上4.0点以下
優:平均点3.5点以上3.8点未満
良:平均点3.0点以上3.5点未満
可:平均点2.0点以上3.0点未満
不可:平均点2.0点未満 <Suppressing effect of convergence>
Regarding the effect of suppressing the feeling of convergence, the strength of the feeling of convergence immediately after rinsing the oral cavity with water after brushing the teeth was evaluated.
Evaluation criteria 4 points: No sense of convergence 3 points: Almost no sense of convergence 2 points: Feeling of convergence 1 point: Feeling of convergence very strongly Judgment criteria Hide: Average score 3.8 points 4.0 points or less Excellent: Average score 3.5 points or more and less than 3.8 points Good: Average score 3.0 points or more and less than 3.5 points Possible: Average score 2.0 points or more and less than 3.0 points Impossible: Average score less than 2.0 points
<収斂感の抑制効果の持続性>
収斂感の抑制効果の持続性に関しては、歯みがき後に水で口腔内をすすいだ後、収斂感を感じなかった時間に関して評価を行った。
評価基準
4点:25分以上(刺激は感じなかった)
3点:15分以上25分未満
2点:5分以上15分未満
1点:5分未満
判定基準
優:平均点3.5点以上4.0点以下
良:平均点3.0点以上3.5点未満
可:平均点2.0点以上3.0点未満
不可:平均点2.0点未満 <Durability of the effect of suppressing the feeling of convergence>
Regarding the sustainability of the effect of suppressing the feeling of convergence, the time when the feeling of convergence was not felt after rinsing the oral cavity with water after brushing the teeth was evaluated.
Evaluation criteria 4 points: 25 minutes or more (no irritation was felt)
3 points: 15 minutes or more and less than 25 minutes 2 points: 5 minutes or more and less than 15 minutes 1 point: less than 5 minutes Judgment criteria Excellent: Average score 3.5 points or more and 4.0 points or less Good: Average score 3.0 points or more 3 . Less than 5 points Possible: Average score of 2.0 points or more and less than 3.0 points Impossible: Average score of less than 2.0 points
収斂感の抑制効果の持続性に関しては、歯みがき後に水で口腔内をすすいだ後、収斂感を感じなかった時間に関して評価を行った。
評価基準
4点:25分以上(刺激は感じなかった)
3点:15分以上25分未満
2点:5分以上15分未満
1点:5分未満
判定基準
優:平均点3.5点以上4.0点以下
良:平均点3.0点以上3.5点未満
可:平均点2.0点以上3.0点未満
不可:平均点2.0点未満 <Durability of the effect of suppressing the feeling of convergence>
Regarding the sustainability of the effect of suppressing the feeling of convergence, the time when the feeling of convergence was not felt after rinsing the oral cavity with water after brushing the teeth was evaluated.
Evaluation criteria 4 points: 25 minutes or more (no irritation was felt)
3 points: 15 minutes or more and less than 25 minutes 2 points: 5 minutes or more and less than 15 minutes 1 point: less than 5 minutes Judgment criteria Excellent: Average score 3.5 points or more and 4.0 points or less Good: Average score 3.0 points or more 3 . Less than 5 points Possible: Average score of 2.0 points or more and less than 3.0 points Impossible: Average score of less than 2.0 points
(B)成分のみの比較例1では、サッパリ感の評価が低く、(A)成分のみの比較例2~6では、口腔粘膜への収斂感の抑制効果が低かった(表5)。これに対し、(A)及び(B)成分の組み合わせである実施例1~28では、サッパリ感、収斂感の抑制効果の評価が良好であり、収斂感の抑制効果も持続していた(表1~4)。中でも、(C)成分をさらに用いた実施例24~28では、収斂感の抑制効果がより良好であった(表4)。
(B)の対照成分のみの比較例8でも、(B)成分のみの比較例1と同様にサッパリ感の評価が低かったが、これに(A)成分を組み合わせた比較例7では、(A)及び(B)成分の組み合わせである比較例2~6と同様、口腔粘膜への収斂感の抑制効果が低く、(B)の対照成分の添加効果が見いだせなかった(表5)。
これらの結果は、本発明の口腔用組成物が口腔内のネバツキ解消によるサッパリ感を発揮でき、収斂感を抑制でき、かつ収斂感の抑制効果を持続させることができることを示している。 In Comparative Example 1 containing only the component (B), the evaluation of the refreshing feeling was low, and in Comparative Examples 2 to 6 containing only the component (A), the effect of suppressing the feeling of convergence on the oral mucosa was low (Table 5). On the other hand, in Examples 1 to 28, which are combinations of the components (A) and (B), the evaluation of the effect of suppressing the feeling of refreshment and the feeling of convergence was good, and the effect of suppressing the feeling of convergence was also sustained (Table). 1-4). Above all, in Examples 24 to 28 in which the component (C) was further used, the effect of suppressing the feeling of convergence was better (Table 4).
In Comparative Example 8 having only the control component of (B), the evaluation of the refreshing feeling was low as in Comparative Example 1 having only the component (B), but in Comparative Example 7 in which the component (A) was combined, (A). ) And (B), as in Comparative Examples 2 to 6, the effect of suppressing the astringency on the oral mucosa was low, and the effect of adding the control component of (B) could not be found (Table 5).
These results indicate that the oral composition of the present invention can exhibit a refreshing feeling by eliminating stickiness in the oral cavity, can suppress the feeling of convergence, and can maintain the effect of suppressing the feeling of convergence.
(B)の対照成分のみの比較例8でも、(B)成分のみの比較例1と同様にサッパリ感の評価が低かったが、これに(A)成分を組み合わせた比較例7では、(A)及び(B)成分の組み合わせである比較例2~6と同様、口腔粘膜への収斂感の抑制効果が低く、(B)の対照成分の添加効果が見いだせなかった(表5)。
これらの結果は、本発明の口腔用組成物が口腔内のネバツキ解消によるサッパリ感を発揮でき、収斂感を抑制でき、かつ収斂感の抑制効果を持続させることができることを示している。 In Comparative Example 1 containing only the component (B), the evaluation of the refreshing feeling was low, and in Comparative Examples 2 to 6 containing only the component (A), the effect of suppressing the feeling of convergence on the oral mucosa was low (Table 5). On the other hand, in Examples 1 to 28, which are combinations of the components (A) and (B), the evaluation of the effect of suppressing the feeling of refreshment and the feeling of convergence was good, and the effect of suppressing the feeling of convergence was also sustained (Table). 1-4). Above all, in Examples 24 to 28 in which the component (C) was further used, the effect of suppressing the feeling of convergence was better (Table 4).
In Comparative Example 8 having only the control component of (B), the evaluation of the refreshing feeling was low as in Comparative Example 1 having only the component (B), but in Comparative Example 7 in which the component (A) was combined, (A). ) And (B), as in Comparative Examples 2 to 6, the effect of suppressing the astringency on the oral mucosa was low, and the effect of adding the control component of (B) could not be found (Table 5).
These results indicate that the oral composition of the present invention can exhibit a refreshing feeling by eliminating stickiness in the oral cavity, can suppress the feeling of convergence, and can maintain the effect of suppressing the feeling of convergence.
Claims (8)
- (A)炭酸塩、炭酸水素塩、硫酸塩、及び塩化物からなる群より選ばれる1種以上、及び
(B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド、エチル-3-(p-メンタン-3-カルボキサミド)アセテート、及びN-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドからなる群より選ばれる1種以上
を含有する口腔用組成物(但し、(A)硫酸ナトリウム及び(B)エチル-3-(p-メンタン-3-カルボキサミド)アセテートを含有する歯磨剤組成物を除く)。 (A) One or more selected from the group consisting of carbonates, hydrogen carbonates, sulfates, and chlorides, and (B) N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5. -From the group consisting of dimethylcyclohexane-1-carboxamide, ethyl-3- (p-menthan-3-carboxamide) acetate, and N- (2- (2-pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide. Oral compositions containing one or more of the selected (except for dentin compositions containing (A) sodium sulfate and (B) ethyl-3- (p-menthan-3-carboxamide) acetate). - 以下の少なくともいずれか1つを満たす、請求項1に記載の口腔用組成物:
炭酸塩が、炭酸ナトリウム、炭酸カリウム、及び炭酸マグネシウムからなる群より選ばれる1種以上であること;
炭酸水素塩が、炭酸水素ナトリウム、炭酸水素カリウム、炭酸水素カルシウム、及び炭酸水素マグネシウムからなる群より選ばれる1種以上であること;
硫酸塩が、硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸アルミニウムカリウム、硫酸アルミニウムナトリウム、及び硫酸アルミニウムアンモニウムからなる群より選ばれる1種以上であること;及び
塩化物が、塩化ナトリウム、塩化カリウム、及び塩化マグネシウムからなる群より選ばれる1種以上であること。 The oral composition according to claim 1, which satisfies at least one of the following:
The carbonate is at least one selected from the group consisting of sodium carbonate, potassium carbonate, and magnesium carbonate;
Bicarbonate is at least one selected from the group consisting of sodium hydrogen carbonate, potassium hydrogen carbonate, calcium hydrogen carbonate, and magnesium hydrogen carbonate;
The sulfate is at least one selected from the group consisting of sodium sulfate, potassium sulfate, magnesium sulfate, potassium aluminum sulfate, sodium aluminum sulfate, and ammonium aluminum sulfate; and the chloride is sodium chloride, potassium chloride, and At least one selected from the group consisting of magnesium chloride. - (A)成分の含有量が、0.1~10質量%である、請求項1又は2に記載の口腔用組成物。 The oral composition according to claim 1 or 2, wherein the content of the component (A) is 0.1 to 10% by mass.
- (B)成分の含有量が、0.00001~0.1質量%である、請求項1~3のいずれか1項に記載の口腔用組成物。 The oral composition according to any one of claims 1 to 3, wherein the content of the component (B) is 0.00001 to 0.1% by mass.
- (C):ノニオン性界面活性剤をさらに含有する、請求項1~4のいずれか1項に記載の口腔用組成物。 (C): The oral composition according to any one of claims 1 to 4, further containing a nonionic surfactant.
- (C)成分が、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテル及びポリグリセリン脂肪酸エステルからなる群より選ばれる1種以上を含む、請求項5に記載の口腔用組成物。 The oral composition according to claim 5, wherein the component (C) contains at least one selected from the group consisting of polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether, and polyglycerin fatty acid ester.
- (C)成分の含有量が、0.1~1質量%である、請求項5又は6に記載の口腔用組成物。 The oral composition according to claim 5 or 6, wherein the content of the component (C) is 0.1 to 1% by mass.
- 歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤である請求項1~7のいずれか1項に記載の口腔用組成物。 The oral composition according to any one of claims 1 to 7, which is a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180087610.8A CN116669680A (en) | 2020-12-28 | 2021-11-30 | Oral composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-219311 | 2020-12-28 | ||
JP2020219311A JP2022104233A (en) | 2020-12-28 | 2020-12-28 | Composition for oral cavity |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022145163A1 true WO2022145163A1 (en) | 2022-07-07 |
Family
ID=82260402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/043896 WO2022145163A1 (en) | 2020-12-28 | 2021-11-30 | Composition for oral cavity |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2022104233A (en) |
CN (1) | CN116669680A (en) |
WO (1) | WO2022145163A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013129600A (en) * | 2011-12-20 | 2013-07-04 | Lion Corp | Dentifrice composition |
JP2015182983A (en) * | 2014-03-25 | 2015-10-22 | ライオン株式会社 | Dentifrice composition |
WO2018131575A1 (en) * | 2017-01-10 | 2018-07-19 | 高砂香料工業株式会社 | Methylmenthol derivative and cool-sensation imparter composition containing same |
JP2019182788A (en) * | 2018-04-11 | 2019-10-24 | ライオン株式会社 | Dentifrice composition |
-
2020
- 2020-12-28 JP JP2020219311A patent/JP2022104233A/en active Pending
-
2021
- 2021-11-30 CN CN202180087610.8A patent/CN116669680A/en active Pending
- 2021-11-30 WO PCT/JP2021/043896 patent/WO2022145163A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013129600A (en) * | 2011-12-20 | 2013-07-04 | Lion Corp | Dentifrice composition |
JP2015182983A (en) * | 2014-03-25 | 2015-10-22 | ライオン株式会社 | Dentifrice composition |
WO2018131575A1 (en) * | 2017-01-10 | 2018-07-19 | 高砂香料工業株式会社 | Methylmenthol derivative and cool-sensation imparter composition containing same |
JP2019182788A (en) * | 2018-04-11 | 2019-10-24 | ライオン株式会社 | Dentifrice composition |
Also Published As
Publication number | Publication date |
---|---|
JP2022104233A (en) | 2022-07-08 |
CN116669680A (en) | 2023-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5233399B2 (en) | Oral spray composition and oral preparation | |
JP2022000420A (en) | Oral cavity composition | |
CN107613948B (en) | Oral composition | |
JP2006347986A (en) | Composition for oral cavity | |
JP6911845B2 (en) | Oral composition | |
WO2022145163A1 (en) | Composition for oral cavity | |
JP2009107988A (en) | Dentifrice composition | |
JP7347916B2 (en) | dentifrice composition | |
JP7255587B2 (en) | Oral composition and α-olefin sulfonate bitterness improver | |
WO2022145161A1 (en) | Composition for oral cavity | |
JP2022001557A (en) | Pain suppressant for oral mucositis or oral infection and oral composition containing the same | |
WO2022145166A1 (en) | Composition for oral use | |
JP6435852B2 (en) | Oral composition and method for preventing discoloration of oral composition | |
WO2022145167A1 (en) | Oral composition | |
JP7523346B2 (en) | Oral Composition | |
JP7073402B2 (en) | Oral composition | |
WO2022145162A1 (en) | Composition for oral cavity | |
JP7064938B2 (en) | Oral composition | |
WO2022145160A1 (en) | Composition for oral cavity | |
WO2023063268A1 (en) | Non-aqueous composition for oral cavity | |
JP6897676B2 (en) | Oral composition | |
WO2022102628A1 (en) | Composition for oral cavity | |
JP6914654B2 (en) | Oral composition | |
WO2022075422A1 (en) | Dentifrice composition | |
WO2021235424A1 (en) | Composition for oral cavity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21915024 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180087610.8 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21915024 Country of ref document: EP Kind code of ref document: A1 |